UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
———————
FORM 10-Q
———————
þ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended June 30, 2010
Or
¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Transition Period From _________ to _________
CROSS COUNTRY HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
Delaware | 0-33169 | 13-4066229 |
(State or other jurisdiction of | Commission file number | (I.R.S. Employer |
6551 Park of Commerce Blvd, N.W.
Boca Raton, Florida 33487
(Address of principal executive offices)(Zip Code)
(561) 998-2232
(Registrants telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). o Yes o No
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act:
Large accelerated filer ¨ Accelerated filer þ
Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller Reporting Company ¨
Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ
The registrant had outstanding 31,087,586 shares of Common Stock, par value $0.0001 per share, as of July 31, 2010.
INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS
In addition to historical information, this Form 10-Q contains statements relating to our future results (including certain projections and business trends) that are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and are subject to the safe harbor created by those sections. Words such as expects, anticipates, intends, plans, believes, estimates, suggests, seeks, will and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expre ssed or implied by these forward-looking statements. These factors include, but are not limited to, the following: our ability to attract and retain qualified nurses, physicians and other healthcare personnel, costs and availability of short-term housing for our travel healthcare professionals, demand for the healthcare services we provide, both nationally and in the regions in which we operate, the functioning of our information systems, the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business, our clients ability to pay us for our services, our ability to successfully implement our acquisition and development strategies, the effect of liabilities and other claims asserted against us, the effect of competition in the markets we serve, our ability to successfully defend the Company, its subsidiaries, and its officers and directors on the merits of any lawsuit or determine its potential liability, if any, and other factors set f orth in Item 1.A. Risk Factors in the Companys Annual Report on Form 10-K for the year ended December 31, 2009, as filed and updated in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect managements opinions only as of the date of this filing. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) our strategy, which is based in part on this analysis, will be successful. The Company undertakes no obligation to update or revise forward-looking statements.
All references to we, us, our, or Cross Country in this Quarterly Report on Form 10-Q mean Cross Country Healthcare, Inc., its subsidiaries and affiliates.
CROSS COUNTRY HEALTHCARE, INC.
INDEX
FORM 10-Q
June 30, 2010
i
PART I. FINANCIAL INFORMATION
Item 1.
Condensed Consolidated Financial Statements
Cross Country Healthcare, Inc.
Condensed Consolidated Balance Sheets
(Unaudited, amounts in thousands)
|
| June 30, |
|
| December 31, |
| ||
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and short-term cash investments |
| $ | 10,300 |
|
| $ | 8,569 |
|
Accounts receivable, less allowance for doubtful accounts of $3,908 in 2010 and $4,545 in 2009 |
|
| 64,299 |
|
|
| 70,172 |
|
Deferred tax assets |
|
| 12,622 |
|
|
| 11,794 |
|
Income taxes receivable |
|
| 479 |
|
|
| 7,405 |
|
Other current assets |
|
| 7,684 |
|
|
| 8,268 |
|
Total current assets |
|
| 95,384 |
|
|
| 106,208 |
|
|
|
|
|
|
|
|
|
|
Property and equipment, net of accumulated depreciation of $45,935 in 2010 and $41,760 in 2009 |
|
| 16,488 |
|
|
| 19,706 |
|
Trademarks, net |
|
| 62,784 |
|
|
| 62,858 |
|
Goodwill, net |
|
| 143,194 |
|
|
| 130,701 |
|
Other identifiable intangible assets, net |
|
| 26,573 |
|
|
| 28,572 |
|
Debt issuance costs, net |
|
| 2,575 |
|
|
| 1,536 |
|
Non-current deferred tax assets |
|
| 5,144 |
|
|
| 5,390 |
|
Other long-term assets |
|
| 1,276 |
|
|
| 1,618 |
|
Total assets |
| $ | 353,418 |
|
| $ | 356,589 |
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses |
| $ | 7,531 |
|
| $ | 8,143 |
|
Accrued employee compensation and benefits |
|
| 17,342 |
|
|
| 16,140 |
|
Current portion of long-term debt |
|
| 6,047 |
|
|
| 5,733 |
|
Interest rate swaps-current |
|
| 532 |
|
|
| 1,427 |
|
Other current liabilities |
|
| 3,628 |
|
|
| 3,113 |
|
Total current liabilities |
|
| 35,080 |
|
|
| 34,556 |
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
| 50,303 |
|
|
| 56,781 |
|
Other long-term liabilities |
|
| 18,705 |
|
|
| 19,181 |
|
Total liabilities |
|
| 104,088 |
|
|
| 110,518 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Common stock |
|
| 3 |
|
|
| 3 |
|
Additional paid-in capital |
|
| 241,914 |
|
|
| 240,870 |
|
Accumulated other comprehensive loss |
|
| (3,077 | ) |
|
| (2,979 | ) |
Retained earnings |
|
| 10,490 |
|
|
| 8,177 |
|
Total stockholders' equity |
|
| 249,330 |
|
|
| 246,071 |
|
Total liabilities and stockholders' equity |
| $ | 353,418 |
|
| $ | 356,589 |
|
See accompanying notes to the condensed consolidated financial statements
1
Cross Country Healthcare, Inc.
Condensed Consolidated Statements of Income
(Unaudited, amounts in thousands, except per share data)
|
| Three Months Ended |
| Six Months Ended |
| ||||||||
|
| 2010 |
| 2009 |
| 2010 |
| 2009 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Revenue from services |
| $ | 117,837 |
| $ | 149,046 |
| $ | 239,198 |
| $ | 324,463 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating expenses |
|
| 84,185 |
|
| 109,448 |
|
| 171,913 |
|
| 241,032 |
|
Selling, general and administrative expenses |
|
| 27,322 |
|
| 31,606 |
|
| 55,207 |
|
| 65,044 |
|
Bad debt expense |
|
| (211 | ) |
| 171 |
|
| |
|
| 76 |
|
Depreciation |
|
| 2,221 |
|
| 2,306 |
|
| 4,374 |
|
| 4,611 |
|
Amortization |
|
| 963 |
|
| 1,018 |
|
| 1,924 |
|
| 2,041 |
|
Total operating expenses |
|
| 114,480 |
|
| 144,549 |
|
| 233,418 |
|
| 312,804 |
|
Income from operations |
|
| 3,357 |
|
| 4,497 |
|
| 5,780 |
|
| 11,659 |
|
Other (income) expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange (income) loss |
|
| (28 | ) |
| 86 |
|
| 15 |
|
| 13 |
|
Interest expense, net |
|
| 1,127 |
|
| 1,513 |
|
| 2,183 |
|
| 3,214 |
|
Income before income taxes |
|
| 2,258 |
|
| 2,898 |
|
| 3,582 |
|
| 8,432 |
|
Income tax expense |
|
| 1,080 |
|
| 606 |
|
| 1,269 |
|
| 3,104 |
|
Net income |
| $ | 1,178 |
| $ | 2,292 |
| $ | 2,313 |
| $ | 5,328 |
|
Net income per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
| $ | 0.04 |
| $ | 0.07 |
| $ | 0.07 |
| $ | 0.17 |
|
Diluted |
| $ | 0.04 |
| $ | 0.07 |
| $ | 0.07 |
| $ | 0.17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
| 31,041 |
|
| 30,791 |
|
| 31,025 |
|
| 30,783 |
|
Diluted |
|
| 31,220 |
|
| 30,953 |
|
| 31,187 |
|
| 30,943 |
|
See accompanying notes to the condensed consolidated financial statements
2
Cross Country Healthcare, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited, amounts in thousands)
|
| Six Months Ended |
| ||||
|
| 2010 |
| 2009 |
| ||
|
|
|
|
|
| ||
Operating activities |
|
|
|
|
| ||
Net income |
| $ | 2,313 |
| $ | 5,328 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
Depreciation |
|
| 4,374 |
|
| 4,611 |
|
Amortization |
|
| 1,924 |
|
| 2,041 |
|
Bad debt expense |
|
| |
|
| 76 |
|
Deferred income tax benefit |
|
| (751 | ) |
| (914 | ) |
Other noncash charges |
|
| 1,553 |
|
| 1,554 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
Accounts receivable |
|
| 5,826 |
|
| 35,232 |
|
Other current assets |
|
| 580 |
|
| 3,516 |
|
Income taxes |
|
| 7,240 |
|
| 2,029 |
|
Accounts payable and accrued expenses |
|
| 264 |
|
| (3,109 | ) |
Other liabilities |
|
| 351 |
|
| 94 |
|
Net cash provided by operating activities |
|
| 23,674 |
|
| 50,458 |
|
|
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
|
Other acquisition related payments |
|
| (12,826 | ) |
| (7,539 | ) |
Purchases of property and equipment |
|
| (681 | ) |
| (1,642 | ) |
Net cash used in investing activities |
|
| (13,507 | ) |
| (9,181 | ) |
|
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
|
Repayment of debt |
|
| (10,648 | ) |
| (52,732 | ) |
Proceeds from issuance of debt |
|
| 4,000 |
|
| 12,575 |
|
Debt issuance costs |
|
| (1,480 | ) |
| |
|
Repurchase of stock for restricted stock tax withholdings |
|
| (200 | ) |
| (48 | ) |
Exercise of stock options |
|
| |
|
| 76 |
|
Tax benefit of stock option exercises |
|
| |
|
| 2 |
|
Net cash used in financing activities |
|
| (8,328 | ) |
| (40,127 | ) |
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
| (108 | ) |
| 214 |
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents |
|
| 1,731 |
|
| 1,364 |
|
Cash and cash equivalents at beginning of period |
|
| 8,569 |
|
| 10,173 |
|
Cash and cash equivalents at end of period |
| $ | 10,300 |
| $ | 11,537 |
|
See accompanying notes to the condensed consolidated financial statements
3
CROSS COUNTRY HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
1.
ORGANIZATION AND BASIS OF PRESENTATION
The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). All material intercompany transactions and balances have been eliminated in consolidation. The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles for complete financial statements. The preparation of consolidated financial statements, in conformity with accounting principles generally accepted in the United States, requires management to make estimates and assumptions that affect the reported amounts in the conde nsed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These operating results are not necessarily indicative of the results that may be expected for the year ending December 31, 2010.
Unless otherwise disclosed in the notes to the condensed consolidated financial statements, the estimated fair value of financial assets and liabilities approximates carrying value. Subsequent events have been evaluated through the filing date of these unaudited condensed consolidated financial statements.
These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2009 included in the Companys Annual Report on Form 10-K as filed with the Securities and Exchange Commission. The December 31, 2009 condensed consolidated balance sheet included herein was derived from the December 31, 2009 audited consolidated balance sheet included in the Companys Annual Report on Form 10-K.
Certain prior year amounts have been reclassified to conform to the current period presentation.
2.
COMPREHENSIVE INCOME
Total comprehensive income includes net income, foreign currency translation adjustments, net changes in the fair value of hedging transactions, and net changes in the fair value of marketable securities available for sale, net of any related deferred taxes.
The table that follows describes the components of comprehensive income in the three and six month periods ending June 30, 2010 and 2009:
Cross Country Healthcare, Inc.
Consolidated Statements of Other Comprehensive Income
(Amounts in thousands)
|
| Three Months Ended |
| Six Months Ended |
| ||||||||
|
| 2010 |
| 2009 |
| 2010 |
| 2009 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Net income |
| $ | 1,178 |
| $ | 2,292 |
| $ | 2,313 |
| $ | 5,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive (loss) income, before tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
| (162 | ) |
| 1,649 |
|
| (568 | ) |
| 1,354 |
|
Net change in fair value of hedging transactions |
|
| 411 |
|
| 336 |
|
| 762 |
|
| 429 |
|
Net change in fair value of marketable securities |
|
| (30 | ) |
| 255 |
|
| 14 |
|
| 363 |
|
Other comprehensive income, before tax |
|
| 219 |
|
| 2,240 |
|
| 208 |
|
| 2,146 |
|
Income tax expense related to items of other comprehensive income |
|
| 149 |
|
| 221 |
|
| 305 |
|
| 300 |
|
Other comprehensive income (loss), net of tax |
|
| 70 |
|
| 2,019 |
|
| (97 | ) |
| 1,846 |
|
Comprehensive income |
| $ | 1,248 |
| $ | 4,311 |
| $ | 2,216 |
| $ | 7,174 |
|
4
Certain of the Companys foreign operations use their respective local currency as their functional currency. In accordance with the Foreign Currency Matters Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC), assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency translation is included in accumulated other comprehensive loss (OCI) in the accompanying condensed consolidated balance sheets and was $2.9 million and $2.3 million at June 30, 2010 and December 31, 2009, respectively.
The net change in fair value of hedging transactions (including effective hedging reclassified to interest expense at cash settlement), related to the Companys interest rate swap agreements, is included in accumulated OCI in the accompanying condensed consolidated balance sheets and was $0.3 million and $0.7 million, net of deferred taxes, at June 30, 2010 and December 31, 2009, respectively.
The net change in fair value of marketable securities is included in accumulated OCI in the accompanying condensed consolidated balance sheets and was less than $0.1 million, net of deferred taxes as of June 30, 2010 and December 31, 2009.
3.
EARNINGS PER SHARE
In accordance with the requirements of the Earnings Per Share Topic of the FASB ASC, basic earnings per share is computed by dividing net income by the weighted average number of shares outstanding including the vested portion of restricted shares. The denominator used to calculate diluted earnings per share reflects the dilutive effects of stock options, stock appreciation rights and nonvested restricted stock (as calculated utilizing the treasury stock method). Certain shares of common stock that are issuable upon the exercise of options have been excluded from per share calculations because their effect would have been anti-dilutive.
4.
ACQUISITIONS
MDA Holdings, Inc.
In September 2008, the Company consummated the acquisition of substantially all of the assets of privately-held MDA Holdings, Inc. and its subsidiaries and all of the outstanding stock of Jamestown Indemnity Ltd. (the Captive), a Cayman Island company and wholly-owned subsidiary (collectively, MDA). This transaction included an earnout provision based on 2008 and 2009 performance criteria. This contingent consideration was not related to the sellers continued employment. In April 2009, the Company paid $6.7 million, related to the 2008 performance. In April 2010, the Company paid $12.8 million, related to the 2009 performance, satisfying all earnout amounts potentially due to the seller in accordance with the asset purchase agreement. Earnout payments were allocated to goodwill as additional purchase price, in accordance with the Business Combinations Topic of the FASB ASC. In May 2010, $1.7 mil lion was released to the seller from the indemnification escrow account leaving a balance of $5.4 million.
Assent Consulting
In July 2007, the Company completed the acquisition of all of the shares of privately-held Assent Consulting (Assent). This transaction included an earnout provision based on 2007 and 2008 performance criteria. This contingent consideration was not related to the sellers employment. In April 2008, the Company paid $4.6 million related to 2007 performance satisfying all earnout amounts potentially due to the seller in accordance with the asset purchase agreement. Approximately $2.0 million of the payment was being held in escrow, subject to forfeiture to the Company, to the extent a 2008 performance milestone was not achieved. Based on 2008 performance, the full amount was released to the sellers in the first quarter of 2009. The entire payment was allocated to goodwill as additional purchase price, in accordance with the Business Combinations Topic of the FASB ASC. In addition, in the first quarter of 2 009, the escrow for post-closing liabilities of $1.0 million was released to the sellers.
AKOS Limited
In June 2007, the Company acquired all of the shares of privately-held AKOS Limited (AKOS), based in the United Kingdom. This transaction included an earnout provision based on 2007 and 2008 performance, as defined by the share purchase agreement. In the first quarter of 2008, the Company paid £1.1 million (approximately $2.1 million) related to the 2007 performance. In the second quarter of 2009, the Company paid the sellers approximately £0.5 million (approximately $0.7 million) related to the 2008 performance. The payments have been allocated to goodwill as additional purchase price, in accordance with the Business Combinations Topic of the FASB ASC.
5
5.
RESERVES FOR CLAIMS
Workers compensation benefits are provided under a partially self-insured plan. For workers compensation claims reported prior to September 1, 2009, the insurance carrier required the Company to fund a reserve for payment of claims. Those funds were maintained by the insurance carrier. Effective September 1, 2009, the Company completely moved from a pre-funded program to a letter of credit structure to guarantee payments of claims. At June 30, 2010 and December 31, 2009, the Company had outstanding $6.9 million and $7.1 million, respectively, standby letters of credit related to this new structure.
6.
DEBT
At June 30, 2010 and December 31, 2009, long-term debt consisted of the following:
|
| June 30, 2010 |
|
| December 31, |
| ||
|
| (Amounts in thousands) |
| |||||
|
|
|
|
|
|
|
|
|
Term loan, interest 2.35% at June 30, 2010 and 1.99% at December 31, 2009 |
| $ | 55,769 |
|
| $ | 62,109 |
|
Capital lease obligations |
|
| 581 |
|
|
| 405 |
|
Total debt |
|
| 56,350 |
|
|
| 62,514 |
|
Less current portion |
|
| (6,047 | ) |
|
| (5,733 | ) |
Long-term debt |
| $ | 50,303 |
|
| $ | 56,781 |
|
The Companys senior secured revolving credit facility entered into on November 10, 2005 was amended and restated as of September 9, 2008 (Credit Agreement) in connection with the acquisition of MDA. The Credit Agreement kept in place an existing $75.0 million revolving credit facility, maturing in November 2010, and provided for a 5-year $125.0 million term loan facility with Wachovia Capital Markets, LLC and certain of its affiliates, Banc of America Securities LLC and certain other lenders.
On May 28, 2010, the Company entered into a first amendment to its Credit Agreement with the lenders party thereto and Wells Fargo Bank, National Association (successor by merger to Wachovia Bank, National Association) as Administrative Agent. The Credit Agreement amendment, among other things, extends the maturity date of the revolving credit facility from November 2010 to September 2013 to be coterminous with the term loan facility, and reduces the existing revolving credit facility to $50.0 million, and the sublimit for letters of credit to $20.0 million. The Company paid $1.5 million of financing fees related to this amendment, that have been capitalized as debt issuance costs on the condensed consolidated balance sheet as of June 30, 2010. Debt issuance costs related to this amendment are being amortized on a straight-line basis over the remaining term of the Credit Agreement. In addition, the Company w rote off an immaterial amount of debt issuance costs related to the reduction of the size of the revolving credit facility.
As of June 30, 2010, the Company did not have any borrowings outstanding under its revolving credit facility, but had $12.5 million of standby letters of credit outstanding under this facility, leaving $37.5 million available for borrowing.
In addition to the above mentioned changes, the terms of the Credit Agreement were adjusted to reflect customary covenants for similarly leveraged deals. As of June 30, 2010, interest on its revolving credit facility was based on LIBOR plus a margin of 3.50% or Base Rate (as defined by the Credit Agreement) plus a margin of 2.50%. The Company is required to pay a quarterly commitment fee on the average daily unused portion of the revolving loan facility, which, as of June 30, 2010 was 0.625%. The interest rate spreads on its term loans remained unchanged, and as of June 30, 2010 were based on LIBOR plus a margin of 2.00% or Base Rate plus a margin of 1.00%.
The table below summarizes what the Company believes are the key financial covenants, as defined by the Credit Agreement, as amended, and its corresponding actual performance as of June 30, 2010.
|
| Requirement |
| Actual |
Maximum Permitted Leverage Ratio (a) |
| 2.50 to 1.00 |
| 2.00 to 1.00 |
|
|
|
|
|
Minimum Fixed Charge Coverage Ratio (b) |
| 1.75 to 1.00 |
| 10.42 to 1.00 |
|
|
|
|
|
Maximum Capital Expenditures for 2010 (c) |
| $16.5 million |
| $0.7 million |
(a)
The Companys Leverage Ratio must not be greater than 2.50 to 1.00 for the duration of the Credit Agreement, September 2013.
6
(b)
The Companys Fixed Charge Coverage Ratio (as defined by the Credit Agreement) must not be less than: 1) 1.75 to 1.00 through December 31, 2010; 2) 1.50 to 1.00 for the fiscal year 2011; 3) 1.25 to 1.00 for the fiscal year 2012 and 4) 1.15 to 1.00 thereafter.
(c)
Aggregate amount of Capital Expenditures in any fiscal year may not exceed: 1) $4.0 million in the fiscal year 2010; 2) $5.0 million in the fiscal year 2011; and $7.0 million in the fiscal year 2012. However, the limit may be increased in any fiscal year by the amount of Capital Expenditures that were permitted but not made in the immediately preceding fiscal year, which is included in the table above.
Effective with the May 2010 amendment, the limitation on the Companys ability to repurchase its common stock and declare and pay cash dividends on its common stock has been adjusted. The Credit Agreement, as amended, provides for an amount allowed for stock repurchases/dividends subsequent to May 28, 2010, that is the lesser of $25.0 million and 50% of cumulative Consolidated Net Income (as defined by the Credit Agreement) for each fiscal quarter after March 31, 2010 where financial statements have been delivered; provided, that the Companys Debt/EBITDA ratio (as defined by the Credit Agreement), after giving effect to the transaction, is less than 1.00 to 1.00 and there is $40.0 million in cash or available cash under its revolving loan facility. However, if the Companys Debt/EBITDA ratio , after giving effect to the transaction is less than 2.00 to 1.00 but equal to or greater than 1.00 to 1.00, and ther e are no amounts outstanding under the revolving credit facility (other than letters of credit), the allowable amount for repurchases/dividends is $2.5 million. The Companys requirement to obtain lender consent for acquisitions has also been adjusted. Effective with the May 2010 amendment, the Company is required to obtain the consent of its lenders to complete any acquisition which exceeds $20.0 million or would cause the Company to exceed $50.0 million in aggregate cash and non-cash consideration for Permitted Acquisitions (as defined by the Credit Agreement) during the term of the Credit Agreement (excluding the MDA acquisition).
Long-term debt includes capital lease obligations that are subordinate to the Companys senior secured facility.
Aggregate scheduled maturities of long-term debt as of June 30, 2010, are as follows:
Through Year Ending December 31 (Amounts in thousands): | |||
2010 |
| $ | 2,837 |
2011 |
|
| 7,957 |
2012 |
|
| 18,473 |
2013 |
|
| 27,063 |
2014 |
|
| 20 |
Thereafter |
|
| |
|
| $ | 56,350 |
7.
INTEREST RATE SWAP AGREEMENTS
The Company uses derivative instruments to manage the fluctuations in cash flows resulting from interest rate risk on variable-rate debt financing. The objective of the hedges is to reduce the exposure to fluctuations in floating interest rates tied to LIBOR borrowings as required by the Companys credit agreement and not for trading purposes. The interest rate swap agreements involve the receipt of variable rate amounts in exchange for fixed rate interest payments over the life of the agreement without an exchange of the underlying principal amount. As of June 30, 2010, the Company had designated 100% of its interest payments on its variable rate debt as the hedged forecasted transactions.
Pursuant to the provisions of the Credit Agreement and not for trading purposes, in October 2008, the Company entered into two interest rate swap agreements, both with effective dates of October 9, 2008 and termination dates of October 9, 2010. The Company was required to execute Interest Rate Contract(s) (as defined in the Credit Agreement) to hedge its variable interest rate exposure in an aggregate amount of at least 40% of its $125.0 million term loan facility, or $50.0 million, for at least 2 years. No initial investments were made to enter into these agreements. The interest rate swap agreements require the Company to pay a fixed rate to the respective counterparty (fixed rate of 3.1625% per annum on a notional amount of $50.0 million and a fixed rate of 2.75% on $20.0 million), and to receive from the respective counterparty, interest payments, based on the applicable notional amounts and 1 month LIBOR, with no exchang es of notional amounts. The interest rate swaps effectively fixed the interest on $70.0 million of the Companys term debt for a period of 2 years at 3.04%, plus the applicable LIBOR spread.
7
The Company has formally documented the hedging relationships and has accounted for these derivatives as cash flow hedges. Gains or losses resulting from changes in the fair value of these agreements have been recorded in OCI, net of tax, until the hedged item is recognized in earnings. The Company formally assesses, both at the hedges inception and on an ongoing basis, whether the derivatives that are used in the hedging transactions are highly effective in offsetting changes in fair values or cash flows of the hedged items. Any ineffectiveness is recorded directly to interest expense.
In the third quarter of 2009, the Company generated excess cash flow, which, along with cash on hand, allowed it to prepay an additional $22.5 million of term loan borrowings causing its $20.0 million notional amount interest rate swap to become ineffective. Subsequent prepayments were made of $5.0 million in the fourth quarter of 2009 and $4.0 million in the first quarter of 2010. The Company has continued to reclassify the after tax amount of estimated ineffectiveness from accumulated OCI to interest expense in the accompanying condensed consolidated income statement related to these prepayments, which was immaterial for the three and six months ended June 30, 2010. In the three and six month periods ending June 30, 2010, the Company reclassified $0.1 million of the loss in OCI to interest expense coinciding with interest payments on the underlying term loan portion that was hedged.
Changes in the cash flows of the $50.0 million notional amount interest rate swap are expected to remain highly effective at offsetting the changes in overall cash flows (i.e. changes in interest payments) attributable to fluctuations in the LIBOR rates on the Companys variable-rate debt. The Company considers the $50.0 million notional amount interest rate swap to be a cash flow hedge and eligible for hedge accounting. Changes in the fair value of derivatives deemed to be eligible for hedge accounting are reported in accumulated OCI on the condensed consolidated balance sheets. See Note 2 Comprehensive Income.
As of June 30, 2010, the fair value of the interest rate swap agreements was approximately $0.5 million and is a liability on the condensed consolidated balance sheet with an offset to accumulated OCI of $0.4 million and interest expense of $0.1 million (for the ineffective portion remaining balance). Deferred tax benefits of $0.2 million were also recorded to OCI, relating to the interest rate swap agreements leaving a balance of approximately $0.3 million in accumulated OCI related to these swap agreements. As of December 31, 2009, the fair value of the interest rate swap agreements was $1.4 million and was recorded as a liability on the consolidated balance sheet with offsets to accumulated OCI of $1.2 million for the effective portion and interest expense of $0.2 million for the ineffective portion. Deferred tax benefits of $0.5 million were also included in OCI, leaving a balance of $0.7 million as of December 31, 2009.
The Company expects the entire amount of $0.5 million, recorded in accumulated OCI will be reclassified to interest expense through October 9, 2010, coinciding with interest payments on the underlying term loan portion that was hedged. Interest rate swap payments are included in net cash provided by operating activities in the Companys condensed consolidated statement of cash flows.
8.
FAIR VALUE MEASUREMENTS
The Fair Value Measurements and Disclosures Topic of the FASB ASC, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Fair Value Measurements and Disclosures Topic also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
Level 1Quoted prices in active markets for identical assets or liabilities.
Level 2Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
8
During the three and six months ended June 30, 2010, the Companys only financial assets/liabilities required to be measured on a recurring basis were its interest rate swap agreements, its deferred compensation liability included in other long-term liabilities and marketable securities included in other long-term assets. The Company utilizes Level 1 inputs to value marketable securities and its deferred compensation liability and Level 2 inputs to value the interest rate swap agreements. Interest rate swap agreements are recorded at fair value based on available quotations provided by a recognized dealer in such hedging agreements. The Company did not hold any Level 3 assets or liabilities at June 30, 2010 or December 31, 2009. The Fair Value Measurements and Disclosures Topic of the FASB ASC also states that the fair value measurement of a financial asset or financial liability must reflect the nonperformance risk of the entity and the counterparty. Therefore, the impact of the counterpartys creditworthiness will be considered when in an asset position and the Companys credit worthiness will be considered when it is in a liability position. As of June 30, 2010, both counterparties are expected to continue to perform under their contractual terms of the instrument and the creditworthiness did not have a material impact on the fair value of the interest rate swap agreements.
The table below summarizes the estimated fair values of the Companys financial assets and liabilities measured on a recurring basis as of June 30, 2010 and December 31, 2009:
|
| Fair Value Measurements as of |
| Fair Value Measurements as of | ||||||||||||||
(Amounts in thousands) |
| Total |
| Quoted Prices in Active Markets for Identical Assets (Level 1) |
| Significant Other Observable Inputs (Level 2) |
| Total |
| Quoted Prices in Active Markets for Identical Assets (Level 1) |
| Significant Other Observable Inputs (Level 2) | ||||||
Financial Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable securities |
| $ | 137 |
| $ | 137 |
| $ | |
| $ | 123 |
| $ | 123 |
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps-current |
| $ | 532 |
| $ | |
| $ | 532 |
| $ | 1,427 |
| $ | |
| $ | 1,427 |
Deferred compensation |
|
| 1,351 |
|
| 1,351 |
|
| |
|
| 1,376 |
|
| 1,376 |
|
| |
|
| $ | 1,883 |
| $ | 1,351 |
| $ | 532 |
| $ | 2,803 |
| $ | 1,376 |
| $ | 1,427 |
9.
STOCKHOLDERS EQUITY
Stock Repurchase Program
During the six months ended June 30, 2010 and 2009, the Company was restricted, under its Credit Agreement and did not repurchase shares of its common stock. Under its February 2008 authorization, the Company may purchase up to an additional 1,441,139 shares of common stock, subject to the constraints of the Companys Credit Agreement. At June 30, 2010, the Company had approximately 31.1 million shares of common stock outstanding.
Share-Based Payments
During the three and six month periods ended June 30, 2010, $0.7 million and $1.2 million, respectively, was included in selling, general and administrative expenses related to share-based payments. In addition, a net of 78,182 shares of common stock were issued upon vesting of restricted stock awards in the three and six month periods ending June 30, 2010.
During the three and six month periods ended June 30, 2009, $0.4 million and $0.8 million, respectively, was included in selling, general and administrative expenses related to share-based payments. In addition, a net of 22,831 shares of common stock were issued upon vesting of restricted stock awards and 9,831 shares were converted upon exercise of employee stock options, in the three and six month periods ending June 30, 2009.
On May 5, 2010, the Companys shareholders approved an amendment to its 2007 Stock Incentive Plan (Plan) to: (1) increase the number of shares of common stock, par value $0.0001 per share (Common Stock), of the Company that may be issued under the Plan from 1,500,000 shares to 3,500,000 shares and (2) increase the share sub-limit for awards that are not stock appreciation awards that may be granted pursuant to the Plan from 1,200,000 shares to 1,700,000 shares of Common Stock.
9
On June 1, 2010, 205,647 shares of restricted stock at a market price of $8.09 were granted to Directors and key employees of the Company. In addition, 254,000 stock appreciation rights were granted to key employees at a price of $8.09 and a weighted average valuation per share of $2.77. Similar to prior grants, the restricted stock vests ratably over a four year period on the anniversary date of the grant. The stock appreciation rights vest 25% per year over a four year period, expire after seven years and can only be settled with stock.
10.
SEGMENT DATA
The Company reports the following business segments in accordance with the Segment Reporting Topic of the FASB ASC:
·
Nurse and allied staffing - The nurse and allied staffing business segment provides travel nurse and allied staffing services and per diem nurse services primarily to acute care hospitals which include public and private healthcare and for-profit and not-for-profit facilities throughout the U.S. The Company aggregates the different brands that it markets to its customers in this business segment.
·
Physician staffing - The physician staffing business segment provides multi-specialty locum tenens to the healthcare industry in all 50 states.
·
Clinical trials services - The clinical trials services business segment provides clinical trials, drug safety, and regulatory professionals and services on a contract staffing and outsourced basis to companies in the pharmaceutical, biotechnology and medical device industries, as well as to contract research organizations, primarily in the United States, Canada and Europe.
·
Other human capital management services - The other human capital management services business segment includes the combined results of the Company’s education and training and retained search businesses.
Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:
|
| Three Months Ended June 30, |
| Six Months Ended June 30, |
| ||||||||
|
| 2010 |
| 2009 |
| 2010 |
| 2009 |
| ||||
(Amounts in thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from external customers: |
|
|
|
|
|
|
| &n bsp; |
|
|
|
|
|
Nurse and allied staffing |
| $ | 59,817 |
| $ | 78,582 |
| $ | 124,487 |
| $ | 183,611 |
|
Physician staffing |
|
| 31,268 |
|
| 40,747 |
|
| 62,410 |
|
| 79,005 |
|
Clinical trials services |
|
| 15,803 |
|
| 19,403 |
|
| 30,974 |
|
| 40,390 |
|
Other human capital management services |
|
| 10,949 |
|
| 10,314 |
|
| 21,327 |
|
| 21,457 |
|
|
| $ | 117,837 |
| $ | 149,046 |
| $ | 239,198 |
| $ | 324,463 |
|
|
|
|
|
|
|
| & nbsp; |
|
|
|
|
|
|
Contribution income (a): |
|
|
|
|
|
|
|
|
| &nbs p; |
|
|
|
Nurse and allied staffing |
| $ | 6,084 |
| $ | 7,202 |
| $ | 11,980 |
| $ | 17,230 |
|
Physician staffing |
|
| 3,709 |
|
| 4,131 |
|
| 6,591 |
|
| 7,373 |
|
Clinical trials services |
|
| 1,706 |
|
| 2,272 |
|
| 3,284 |
|
| 4,459 |
|
Other human capital management services |
|
| 798 |
|
| 329 |
|
| 1,816 |
|
| 1,258 |
|
|
|
| 12,297 |
|
| 13,934 |
|
| 23,671 |
|
| 30,320 |
|
|
|
|
|
|
|
|
|
| &n bsp; |
|
|
|
|
Unallocated corporate overhead |
|
| 5,756 |
|
| 6,113 |
|
| 11,593 |
|
| 12,009 |
|
Depreciation |
|
| 2,221 |
|
| 2,306 |
|
| 4,374 |
|
| 4,611 |
|
Amortization |
|
| 963 |
|
| 1,018 |
|
| 1,924 |
|
| 2,041 |
|
Income from operations |
| $ | 3,357 |
| $ | 4,497 |
| $ | 5,780 |
| $ | 11,659 |
|
(a)
The Company defines contribution income as income from operations before depreciation, amortization and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance and is provided in accordance with the Segment Reporting Topic of the FASB ASC.
10
11.
COMMITMENTS AND CONTINGENCIES
In July 2010, the Company entered into an agreement to lease 18,000 square feet of space in Pune, India for its in-house information systems and development support services as well as back-office processing services. The agreement is for three years with an option to extend for another two year period. The commitment is to pay approximately $0.2 million per year, with a total commitment of approximately $0.7 million. The commencement of the lease will be September 1, 2010.
In July 2010, the Company renegotiated its lease in Malden, Massachusetts. The new lease, effective July 1, 2010, reduces the space occupied by the Company from approximately 31,662 square feet to approximately 22,767 square feet. In addition, the lease expiration was extended from June 30, 2012 to June 30, 2017, with an option to extend another three years. The revised lease has the effect of reducing the Companys lease payment commitments by approximately $0.2 million through June 30, 2012. However, the extension through 2017 added $1.3 million to the total commitment related to this property.
Contingencies:
Maureen Petray and Carina Higareda v. MedStaff, Inc.
On February 18, 2005, the Companys MedStaff subsidiary became the subject of a purported class action lawsuit (Maureen Petray and Carina Higareda v. MedStaff, Inc.) filed in the Superior Court of California in Riverside County. The lawsuit relates to only MedStaff corporate employees working in California. The claims alleged under this lawsuit are generally similar in nature to those brought by Darrelyn Renee Henry in a lawsuit against the Company, which was dismissed (Darrelyn Renee Henry vs. MedStaff, Inc., et. al.).
The lawsuit alleges, among other things, violations of certain sections of the California Labor Code, the California Business and Professions Code, and recovery of unpaid wages and penalties. MedStaff currently has less than 50 corporate employees in California. The Plaintiffs, Maureen Petray and Carina Higareda, purport to sue on behalf of themselves and all others similarly situated, and allege that MedStaff failed, under California law, to provide meal periods and rest breaks and pay for those missed meal periods and rest breaks; failed to compensate the employees for all hours worked; failed to compensate the employees for working overtime; failed to keep appropriate records to keep track of time worked; failed to pay Plaintiffs and their purported class as required by law. Plaintiffs seek, among other things, an order enjoining MedStaff from engaging in the practices challenged in the complaint and for full restitution of all monies, for interest, for certain penalties provided for by the California Labor Code and for attorneys fees and costs. On February 5, 2007, the court granted class certification. On October 16, 2008, MedStaff filed a Motion to Decertify the class which was denied on December 19, 2008. Trial was scheduled to occur in the second quarter of 2010; however, in December 2009, the Company reached an agreement in principle to settle this matter. As a result, the Company accrued a pre-tax charge of $345,000 (approximately $209,000 after taxes) related to this lawsuit. The final settlement agreement will be subject to court approval.
The Company is also subject to other legal proceedings and claims that arise in the ordinary course of its business. In the opinion of management, the outcome of these other matters will not have a significant effect on the Companys consolidated financial position or results of operations.
12.
INCOME TAXES
The Companys effective tax rate for the full year is estimated to be approximately 42%. The effective tax rate was 47.8% and 35.4% in the three and six months ended June 30, 2010, respectively. The Company had a lower tax rate in the first quarter of 2010 due to certain discrete items, including an immaterial prior year correction related to a tax election the Company made on behalf of a subsidiary acquired in 2008 as part of the MDA acquisition. Excluding these items, the effective tax rate in the three and six months ended June 30, 2010 was 39.6% and 38.7%, respectively.
In accordance with the Income Taxes Topic of the FASB ASC, a reconciliation of the beginning and ending amounts of unrecognized tax benefits, including estimated interest and penalties, is as follows:
|
| (Amounts in thousands) |
| |
Balance at January 1, 2010 |
| $ | 4,443 |
|
Additions based on tax positions related to prior years |
|
| 88 |
|
Additions based on tax positions related to current year |
|
| 314 |
|
Balance at June 30, 2010 |
| $ | 4,845 |
|
11
As of June 30, 2010, the Company had approximately $4.1 million of unrecognized tax benefits, which would affect the effective tax rate if recognized. During the six months ended June 30, 2010, the Company had gross increases of $0.4 million to its current year unrecognized tax benefits related to federal and state tax issues.
The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. The Company had accrued approximately $0.8 million and $0.7 million for the payment of interest and penalties at June 30, 2010 and December 31, 2009, respectively.
The tax years 2006 through 2009 remain open to examination by the major taxing jurisdictions to which the Company is subject, with the exception of certain states in which the statute of limitations has been extended. In April 2010, the Company received a federal tax refund of $5.6 million substantially related to its election, under the Worker, Homeownership, and Business Assistance Act of 2009, of a 5 year carryback period for its 2009 taxable net operating loss.
12
ITEM 2.
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The Companys condensed consolidated financial statements present a consolidation of all its operations. This discussion supplements the detailed information presented in the condensed consolidated financial statements and notes thereto which should be read in conjunction with the consolidated financial statements and related notes contained in the Companys Annual Report on Form 10-K, filed for the year ended December 31, 2009, and is intended to assist the reader in understanding the financial results and condition of the Company.
Overview
We are a diversified leader in healthcare staffing services offering a comprehensive suite of staffing and outsourcing services to the healthcare market. We report our financial results according to four business segments: (1) nurse and allied staffing, (2) physician staffing (locum tenens), (3) clinical trials services and (4) other human capital management services. We believe we are one of the top two providers of travel nurse and allied staffing services in the United States; one of the top three providers of temporary physician staffing services; a leading provider of clinical trials staffing services and retained physician search services; and a provider of educational seminars, specifically for the healthcare marketplace.
We have a diversified revenue mix across business sectors and healthcare customers. For the quarter ended June 30, 2010, our nurse and allied staffing business segment represented approximately 51% of our revenue and is comprised of travel and per diem nurse staffing and travel allied health staffing. Travel nurse staffing represented approximately 37% of our total revenue and 73% of our nurse and allied staffing business segment revenue. Other nurse and allied staffing services include the placement of per diem nurses and allied healthcare professionals, such as radiology technicians, rehabilitation therapists and respiratory therapists. Our physician staffing business segment represented approximately 27% of first quarter 2010 revenue and consists of temporary physician staffing services (locum tenens). Our clinical trials services business segment represented approximately 13% of our revenue and consists of service offerings that include traditional st affing, drug safety monitoring and regulatory services to pharmaceutical and biotechnology customers. Our other human capital management services business segment represented approximately 9% of our revenue and consists of education and training and retained search services.
For the quarter ended June 30, 2010, our revenue was $117.8 million, and net income was $1.2 million, or $0.04 per diluted share. Cash flow provided by operating activities for the six months ended June 30, 2010, was $23.7 million (including a $5.6 million federal income tax refund), which was primarily used to pay the final earnout payment related to our acquisition of privately-held MDA Holdings, Inc. and its subsidiaries and all of the outstanding stock of Jamestown Indemnity Ltd. (the Captive), a Cayman Island company and wholly-owned subsidiary (collectively, MDA), and to repay debt. We ended the second quarter of 2010 with total debt of $56.4 million and $10.3 million of cash, resulting in a ratio of debt, net of cash, to total capitalization of 15.1%.
In general, we evaluate the Companys financial condition and operating results by revenue, contribution income (see Segment Information), and net income. We also use measurement of our cash flow generation and operating and leverage ratios to help us assess our financial condition. In addition, we monitor several key volume and profitability indicators such as number of open orders, contract bookings, number of FTEs, days filled and price.
Nurse and Allied Staffing
Our nurse and allied staffing business results in the second quarter of 2010 reflects the challenging environment we have been operating in since the dramatic deterioration in the economy and national labor markets that began in the third quarter of 2008. However, since the beginning of June, we have experienced a significant increase in demand in most areas of the country, particularly for travel nurse staffing. In addition, relative bookings for our nurse and allied staffing business segment, which measures net weeks booked as a percentage of the average field FTE count, improved from 88% in the first quarter of 2010 to 97% in the second quarter of 2010 and have averaged 114% so far in the third quarter. Based on current trends, we would expect a sequential volume increase in the nurse and allied staffing segment in the fourth quarter 2010.
13
Physician Staffing
We believe the lingering effects of the recession and the weak housing market have delayed the retirement plans of many physicians. These factors, along with fewer surgeries, have resulted in a decrease in demand for temporary physicians, particularly in such specialties as anesthesiology and surgery. We also believe that hospitals and medical groups have experienced financial pressures on their operations which have resulted in less utilization of temporary physicians. Despite this decrease in current demand, we believe the long-term demographic drivers of this business have not changed. These drivers include an aging population demanding more healthcare, an aging physician population from the baby boom generation nearing retirement age, and more females entering the profession, which historically have provided less hours of service. Due to these factors, we believe the long-term prospects for an acute physician shortage is just as strong now as it was before the current downturn. In addition, we believe the increase in the insured population that will result from the enactment of healthcare reform should increase demand for primary care physicians which should benefit our business.
Clinical Trials Services
The environment for clinical trials services weakened during 2009 stemming from a slow-down in clinical trials caused largely by economic factors and financial market conditions, along with uncertainty concerning research and development activities following the recent wave of mergers and acquisitions in the pharmaceutical and biotechnology sectors. Meanwhile, we have been seeing gradual improvement in the core contract staffing component of this business, which represented approximately 95% of the business segments revenue in the second quarter of 2010, while continuing to experience weakness in our drug safety monitoring and regulatory compliance service offerings. Despite the recent industry weaknesses, demographic factors and advances in biotechnology should drive long-term growth for this business segment.
Results of Operations
The following table summarizes, for the periods indicated, selected condensed consolidated statements of income data expressed as a percentage of revenue:
|
|
| Three Months Ended |
|
| Six Months Ended |
| ||||
|
|
| June 30, |
|
| June 30, |
| ||||
|
|
| 2010 |
| 2009 |
|
| 2010 |
| 2009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from services |
|
| 100.0 | % | 100.0 | % |
| 100.0 | % | 100.0 | % |
Direct operating expenses |
|
| 71.4 |
| 73.5 |
|
| 71.9 |
| 74.3 |
|
Selling, general and administrative expenses |
|
| 23.2 |
| 21.2 |
|
| 23.1 |
| 20.0 |
|
Bad debt expense |
|
| (0.2) |
| 0.1 |
|
| - |
| - |
|
Depreciation and amortization |
|
| 2.7 |
| 2.2 |
|
| 2.6 |
| 2.1 |
|
Income from operations |
|
| 2.9 |
| 3.0 |
|
| 2.4 |
| 3.6 |
|
Foreign exchange (income) loss |
|
| (0.0) |
| 0.1 |
|
| 0.0 |
| 0.0 |
|
Interest expense, net |
|
| 1.0 |
| 1.0 |
|
| 0.9 |
| 1.0 |
|
Income before income taxes |
|
| 1.9 |
| 1.9 |
|
| 1.5 |
| 2.6 |
|
Income tax expense |
|
| 0.9 |
| 0.4 |
|
| 0.5 |
| 1.0 |
|
Net income |
|
| 1.0 | % | 1.5 | % |
| 1.0 | % | 1.6 | % |
Acquisitions
MDA Holdings, Inc.
In September 2008, we consummated the acquisition of substantially all of the assets of privately-held MDA Holdings, Inc. and its subsidiaries and all of the outstanding stock of a subsidiary of MDA Holdings, Inc. (collectively, MDA). This transaction included an earnout provision based on 2008 and 2009 performance criteria. This contingent consideration is not related to the sellers continued employment. In the second quarter of 2009, we paid $6.7 million, related to the 2008 performance. In April 2010, we paid $12.8 million, related to the 2009 performance, satisfying all earnout amounts potentially due to the seller in accordance with the asset purchase agreement. The earnout payments were allocated to goodwill as additional purchase price, in accordance with the Business Combinations Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). In addition, in May&nb sp;2010, $1.7 million was released to the seller from the indemnification escrow account leaving a balance of $5.4 million.
14
Assent Consulting
In July 2007, we completed an acquisition of the shares of privately-held Assent Consulting (Assent). This transaction also included an earnout provision based on 2007 and 2008 performance criteria. This contingent consideration was not related to the sellers employment. In the second quarter of 2008, we paid $4.6 million related to 2007 performance satisfying all earnout amounts potentially due to the seller in accordance with the asset purchase agreement. Of this payment, $2.0 million was being held in escrow, subject to forfeiture to us, to the extent a 2008 performance milestone was not achieved. However, based on 2008 performance, the full amount was released to the seller in the first quarter of 2009. The entire payment was allocated to goodwill as additional purchase price, in accordance the Business Combinations Topic of the FASB ASC. In addition, in the first quarter of 2009, the escrow for post-closing liabilities o f $1.0 million was released to the sellers.
AKOS Limited
In June 2007, we acquired all of the shares of privately-held AKOS Limited (AKOS), based in the United Kingdom. This transaction included an earnout provision based on 2007 and 2008 performance, as defined by the share purchase agreement. In the first quarter of 2008, we paid £1.1 million (approximately $2.1 million) related to the 2007 performance. In the second quarter of 2009, we paid the sellers approximately £0.5 million (approximately $0.7 million) related to the 2008 performance. The payments have been allocated to goodwill as additional purchase price, in accordance with the Business Combinations Topic of the FASB ASC.
Goodwill and Other Identifiable Intangible Assets
Goodwill and other intangible assets represented 93% of our stockholders equity as of June 30, 2010. Goodwill and other identifiable intangible assets (including trademarks) from the acquisition of the assets of our predecessor, Cross Country Staffing, a partnership, as well as from subsequent acquisitions were $143.2 million and $89.4 million, respectively, net of accumulated amortization, at June 30, 2010. In accordance with the Intangibles-Goodwill and Other Topic of the FASB ASC, goodwill and certain other identifiable intangible assets are not subject to amortization; instead, we review impairment annually. Other identifiable intangible assets, which are subject to amortization, are being amortized using the straight-line method over their estimated useful lives ranging from 4.5 to 15 years.
Segment Information
We report the following business segments in accordance with the Segment Reporting Topic of the FASB ASC:
·
Nurse and allied staffing - The nurse and allied staffing business segment provides travel nurse and allied staffing services and per diem nurse services primarily to acute care hospitals which include public and private healthcare and for-profit and not-for-profit facilities throughout the U.S. We aggregate the different brands that we market to our customers in this business segment.
·
Physician staffing - The physician staffing business segment provides multi-specialty locum tenens to the healthcare industry in all 50 states.
·
Clinical trials services - The clinical trials services business segment provides clinical trials, drug safety, and regulatory professionals and services on a contract staffing and outsourced basis to companies in the pharmaceutical, biotechnology and medical device industries, as well as to contract research organizations, primarily in the United States, Canada and Europe.
·
Other human capital management services - The other human capital management services business segment includes the combined results of our education and training and retained search businesses.
15
Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:
|
| Three Months Ended June 30, |
| Six Months Ended June 30, |
| ||||||||
|
| 2010 |
| 2009 |
| 2010 |
| 2009 |
| ||||
(Amounts in thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from external customers: |
|
|
|
|
|
|
| &n bsp; |
|
|
|
|
|
Nurse and allied staffing |
| $ | 59,817 |
| $ | 78,582 |
| $ | 124,487 |
| $ | 183,611 |
|
Physician staffing |
|
| 31,268 |
|
| 40,747 |
|
| 62,410 |
|
| 79,005 |
|
Clinical trials services |
|
| 15,803 |
|
| 19,403 |
|
| 30,974 |
|
| 40,390 |
|
Other human capital management services |
|
| 10,949 |
|
| 10,314 |
|
| 21,327 |
|
| 21,457 |
|
|
| $ | 117,837 |
| $ | 149,046 |
| $ | 239,198 |
| $ | 324,463 |
|
|
|
|
|
|
|
| & nbsp; |
|
|
|
|
|
|
Contribution income (a): |
|
|
|
|
|
|
|
|
| &nbs p; |
|
|
|
Nurse and allied staffing |
| $ | 6,084 |
| $ | 7,202 |
| $ | 11,980 |
| $ | 17,230 |
|
Physician staffing |
|
| 3,709 |
|
| 4,131 |
|
| 6,591 |
|
| 7,373 |
|
Clinical trials services |
|
| 1,706 |
|
| 2,272 |
|
| 3,284 |
|
| 4,459 |
|
Other human capital management services |
|
| 798 |
|
| 329 |
|
| 1,816 |
|
| 1,258 |
|
|
|
| 12,297 |
|
| 13,934 |
|
| 23,671 |
|
| 30,320 |
|
|
|
|
|
|
|
|
|
| &n bsp; |
|
|
|
|
Unallocated corporate overhead |
|
| 5,756 |
|
| 6,113 |
|
| 11,593 |
|
| 12,009 |
|
Depreciation |
|
| 2,221 |
|
| 2,306 |
|
| 4,374 |
|
| 4,611 |
|
Amortization |
|
| 963 |
|
| 1,018 |
|
| 1,924 |
|
| 2,041 |
|
Income from operations |
| $ | 3,357 |
| $ | 4,497 |
| $ | 5,780 |
| $ | 11,659 |
|
(a)
We define contribution income as income from operations before depreciation, amortization and other corporate expenses not specifically identified to a reporting segment. Contribution income is a measure used by management to access operations and is provided in accordance with the Segment Reporting Topic of the FASB ASC.
Comparison of Results for the Three Months Ended June 30, 2010 compared to Three Months Ended June 30, 2009
Revenue from services
Revenue from services decreased $31.2 million, or 20.9%, to $117.8 million for the three months ended June 30, 2010, as compared to $149.0 million for the three months ended June 30, 2009. The decrease was due to lower revenue from our nurse and allied staffing business segment, physician staffing and clinical trials services business segments, partially offset by an increase in revenue from our other human capital services business segment. The decrease in revenue reflects the challenging operating environment for our business segments that has resulted in decreased demand from our customers.
Nurse and allied staffing
Revenue from our nurse and allied staffing business segment decreased $18.8 million, or 23.9%, to $59.8 million in the three months ended June 30, 2010, from $78.6 million in the three months ended June 30, 2009, primarily due to lower staffing volume, as well as lower pricing, partially resulting from changes in geographic mix.
The average number of nurse and allied staffing FTEs on contract during the three months ended June 30, 2010, decreased 21.3% from the three months ended June 30, 2009. Average nurse and allied staffing revenue per FTE per day decreased approximately 3.2% in the three months ended June 30, 2010 compared to the three months ended June 30, 2009, primarily due to a decline of 2.6% in the average bill rate in our travel staffing operations and a relatively higher mix of per diem staffing operations, which typically has a lower average bill rate than travel staffing due to the mix of healthcare professionals.
Physician staffing
Revenue from our physician staffing business decreased $9.5 million or 23.3% to $31.3 million for the three months ended June 30, 2010, compared to $40.7 million in the three months ended June 30, 2009. The revenue decline reflects decreased demand for our temporary physician staffing services, and in particular, anesthesiology.
16
Physician staffing days filled is a metric that we use to measure volume in this business segment. Physician staffing days filled is equivalent to total hours filled during the respective period divided by eight hours. Physician staffing days filled decreased 17.6% to 20,657 in the three months ended June 30, 2010, compared to the three months ended June 30, 2009. Revenue per day filled for the three months ended June 30, 2010 was $1,514 a 6.8% decrease from the three months ended June 30, 2009, reflecting an unfavorable change in the mix of specialties. Revenue per day filled is calculated by dividing total physician staffing revenue by days filled for the respective period.
Clinical trials services
Revenue from clinical trials services decreased $3.6 million, or 18.6%, to $15.8 million in the three months ended June 30, 2010, from $19.4 million in the three months ended June 30, 2009. This decline was primarily due to the conclusion, in the third quarter of 2009, of a large clinical trial we were contracted to manage and a decrease in revenue from a specific drug safety contract, partially offset by an increase in revenue from contract staffing, reflecting higher average bill rates. Contract staffing represented approximately 95% of this business segments revenue in the three months ended June 30, 2010 compared to 76% in the three months ended June 30, 2009.
Other human capital management services
Revenue from other human capital management services for the three months ended June 30, 2010, increased $0.6 million, or 6.2%, to $10.9 million from $10.3 million in the three months ended June 30, 2009, primarily reflecting an increase in revenue from our education and training business due to an increase in the number of seminars and higher seminar attendance. This increase was partially offset by a decrease in revenue from our retained search business.
Direct operating expenses
Direct operating expenses are comprised primarily of field employee and independent contractor compensation expenses, housing expenses, travel expenses and field insurance expenses. Direct operating expenses decreased $25.3 million, or 23.1%, to $84.2 million for the three months ended June 30, 2010, as compared to $109.4 million for three months ended June 30, 2009.
As a percentage of total revenue, direct operating expenses represented 71.4% of revenue for the three months ended June 30, 2010, and 73.5% for the three months ended June 30, 2009. The decrease is primarily due to a change in the business mix among segments, coupled with a widening of the bill-pay spread in our travel staffing operations, lower housing costs and lower professional liability expenses.
Selling, general and administrative expenses
Selling, general and administrative expenses decreased $4.3 million, or 13.6%, to $27.3 million for the three months ended June 30, 2010, as compared to $31.6 million for the three months ended June 30, 2009. The decrease in selling, general and administrative expenses was primarily due to our efforts to reduce overhead expenses.
Included in selling, general and administrative expenses is unallocated corporate overhead of $5.8 million for three months ended June 30, 2010, compared to $6.1 million for the three months ended June 30, 2009. As a percentage of consolidated revenue, unallocated corporate overhead was 4.9% for the three month period ended June 30, 2010 and 4.1% for the three month period ended June 30, 2009.
As a percentage of total revenue, selling, general and administrative expenses were 23.2% and 21.2%, for the three months ended June 30, 2010 and 2009, respectively. This increase is primarily due to negative operating leverage.
Bad debt expense
In the three month periods ended June 30, 2010, we reversed $0.2 million of our reserves for bad debt due to the improved quality of our receivables. In the three months ended June 30, 2009, $0.2 million was recorded for bad debt expense representing 0.1% of consolidated revenue from services.
17
Contribution income
Nurse and allied staffing
Contribution income from our nurse and allied staffing segment for the three months ended June 30, 2010, decreased $1.1 million or 15.5%, to $6.1 million from $7.2 million in three months ended June 30, 2009. As a percentage of nurse and allied staffing revenue, segment contribution income was 10.2% for the three months ended June 30, 2010, and 9.2% for the three months ended June 30, 2009. This increase is primarily due to a widening of our bill-pay spread and lower housing expenses as a percentage of revenue, partially offset by negative operating leverage.
Physician staffing
Contribution income from physician staffing for the three months ended June 30, 2010 decreased 10.2% to $3.7 million, from $4.1 million in the three months ended June 30, 2009. As a percentage of physician staffing revenue, contribution income was 11.9% in the three months ended June 30, 2010 compared to 10.1% in the three months ended June 30, 2009. The improvement in contribution income as a percentage of revenue is primarily due to lower professional liability expense in the three months ended June 30, 2010 compared to the three months ended June 30, 2009, reflecting a change in mix to lower risk specialties and geographic locations, as well as better than expected loss development.
Clinical trials services
Contribution income from clinical trials services for the three months ended June 30, 2010, decreased $0.6 million, or 24.9%, to $1.7 million, from $2.3 million in the three months ended June 30, 2009. As a percentage of clinical trials services revenue, segment contribution income was 10.8% in the three months ended June 30, 2010 compared to 11.7% in the three months ended June 30, 2009, primarily due to a significant change in the mix of business.
Other human capital management services
Contribution income from other human capital management services for the three months ended June 30, 2010, increased by $0.5 million, or 142.6%, to $0.8 million, from $0.3 million in the three months ended June 30, 2009 primarily due to an increase from our education and training business. Contribution income as a percentage of other human capital management services revenue was 7.3% for the three months ended June 30, 2010 and 3.2% for the three months ended June 30, 2009, primarily reflecting improved performance in our education and training business.
Depreciation and amortization expense
Depreciation and amortization expense in the three months ended June 30, 2010, totaled $3.2 million as compared to $3.3 million for the three months ended June 30, 2009. As a percentage of revenue, depreciation and amortization expense was 2.7% for the three months ended June 30, 2010 and 2.2% for the three months ended June 30, 2009.
Interest expense, net
Interest expense, net, totaled $1.1 million for the three months ended June 30, 2010 and $1.5 million for the three months ended June 30, 2009. The decrease in interest expense was due to lower average borrowings in the three months ended June 30, 2010, partially offset by a higher average effective interest rate on our borrowings. The effective interest rate on our borrowings was 5.8% for the three month period ended June 30, 2010 and 4.3% for the three month period ended June 30, 2009.
Income tax expense
Income tax expense totaled $1.1 million for the three months ended June 30, 2010, as compared to $0.6 million for the three months ended June 30, 2009. The effective tax rate was 47.8% in the three months ended June 30, 2010, compared to 20.9% in the three months ended June 30, 2009. Both periods were impacted by discrete items. Excluding discrete items, the effective tax rate in the three months ended June 30, 2010 was 39.6% compared to 9.3% in the three months ended June 30, 2009. The unusually low tax rate excluding discrete items in the three months ended June 30, 2009 was due to a change in our estimate of permanent book to tax differences.
18
Comparison of Results for the Six Months Ended June 30, 2010 compared to Six Months Ended June 30, 2009
Revenue from services
Revenue from services decreased $85.3 million, or 26.3%, to $239.2 million for the six months ended June 30, 2010, as compared to $324.5 million for the six months ended June 30, 2009. The decrease was primarily due to a decrease in revenue from our nurse and allied staffing business segment, although all of our business segments contributed to the decrease in consolidated revenue. The decrease in revenue reflects the challenging operating environment all of our business segments have experienced that resulted in decreased demand from our customers.
Nurse and allied staffing
Revenue from our nurse and allied staffing business segment decreased $59.1 million, or 32.2%, to $124.5 million in the six months ended June 30, 2010, from $183.6 million in the six months ended June 30, 2009, primarily due to lower staffing volume.
The average number of nurse and allied staffing FTEs on contract during the six months ended June 30, 2010, decreased 29.1% from the six months ended June 30, 2009. Average nurse and allied staffing revenue per FTE per day decreased approximately 4.1% in the six months ended June 30, 2010 compared to the six months ended June 30, 2009, primarily due to a decline of 2.9% in the average bill rate in our travel staffing operations and a relatively higher mix of per diem staffing operations, which typically has a lower average bill rate than travel staffing due to the mix of healthcare professionals.
Physician staffing
Revenue from our physician staffing business decreased $16.6 million or 21.0% to $62.4 million for the six months ended June 30, 2010, compared to $79.0 million in the six months ended June 30, 2009. The revenue decline reflects decreased demand for our temporary physician staffing services, and in particular, anesthesiology. Physician staffing days filled decreased 17.9% to 40,241 in the six months ended June 30, 2010, compared to the six months ended June 30, 2009. Revenue per day filled for the six months ended June 30, 2010 was $1,551 a 3.8% decrease from the six months ended June 30, 2009, reflecting an unfavorable change in the mix of specialties.
Clinical trials services
Revenue from clinical trials services decreased $9.4 million, or 23.3%, to $31.0 million in the six months ended June 30, 2010, from $40.4 million in the six months ended June 30, 2009. This decline was primarily due to several clinical research projects that ended in the third quarter of 2009, a decrease in revenue from a specific drug safety contract and a decrease in contract staffing volume.
Other human capital management services
Revenue from other human capital management services for the six months ended June 30, 2010, decreased $0.1 million, or 0.6%, to $21.3 million from $21.5 million in the six months ended June 30, 2009, reflecting a decrease in revenue related to the number of retained searches performed and partially offset by an increase in revenue from our education and training business due to higher seminar attendance.
Direct operating expenses
Direct operating expenses are comprised primarily of field employee and independent contractor compensation expenses, housing expenses, travel expenses and field insurance expenses. Direct operating expenses decreased $69.1 million, or 28.7%, to $171.9 million for the six months ended June 30, 2010, as compared to $241.0 million for six months ended June 30, 2009.
As a percentage of total revenue, direct operating expenses represented 71.9% of revenue for the six months ended June 30, 2010, and 74.3% for the six months ended June 30, 2009. The decrease is primarily due to a change in the business mix among segments, coupled with a widening of the bill-pay spread in our travel staffing operations and lower housing costs.
Selling, general and administrative expenses
Selling, general and administrative expenses decreased $9.8 million, or 15.1%, to $55.2 million for the six months ended June 30, 2010, as compared to $65.0 million for the six months ended June 30, 2009. The decrease in selling, general and administrative expenses was primarily due to our efforts to reduce overhead expenses.
19
Included in selling, general and administrative expenses is unallocated corporate overhead of $11.6 million for six months ended June 30, 2010, compared to $12.0 million for the six months ended June 30, 2009. As a percentage of consolidated revenue, unallocated corporate overhead was 4.8% for the six month period ended June 30, 2010 and 3.7% for the six month period ended June 30, 2009. Share-based compensation, included in unallocated corporate overhead, was $1.2 million in the six months ended June 30, 2010 and $0.8 million in the six months ended June 30, 2009.
As a percentage of total revenue, selling, general and administrative expenses were 23.1% and 20.0%, for the six months ended June 30, 2010 and 2009, respectively. This increase is primarily due to negative operating leverage.
Bad debt expense
Bad debt expense was not recorded in the six months ended June 30, 2010, due to the improved quality of receivables. In the six months ended June 30, 2009, bad debt expense was $0.1 million or less than 0.1% of consolidated revenue.
Contribution income
Nurse and allied staffing
Contribution income from our nurse and allied staffing segment for the six months ended June 30, 2010, decreased $5.3 million or 30.5%, to $12.0 million from $17.2 million in six months ended June 30, 2009. As a percentage of nurse and allied staffing revenue, segment contribution income was 9.6% for the six months ended June 30, 2010, and 9.4% for the six months ended June 30, 2009. This increase is primarily due to a widening of our bill-pay spread and lower housing expenses as a percentage of revenue.
Physician staffing
Contribution income from physician staffing for the six months ended June 30, 2010 decreased 10.6% to $6.6 million, from $7.4 million in the six months ended June 30, 2009. As a percentage of physician staffing revenue, contribution income was 10.6% in the six months ended June 30, 2010 compared to 9.3% in the six months ended June 30, 2009. The improvement in contribution income as a percentage of revenue is primarily due to lower professional liability expense in the six months ended June 30, 2010 compared to the six months ended June 30, 2009, reflecting a change in mix to lower risk specialties and geographic locations, as well as better than expected loss development.
Clinical trials services
Contribution income from clinical trials services for the six months ended June 30, 2010, decreased $1.2 million, or 26.4%, to $3.3 million, from $4.5 million in the six months ended June 30, 2009. As a percentage of clinical trials services revenue, segment contribution income was 10.6% in the six months ended June 30, 2010 and 11.0% in the six months ended June 30, 2009. This decrease is primarily due to negative operating leverage.
Other human capital management services
Contribution income from other human capital management services for the six months ended June 30, 2010, increased by $0.6 million, or 44.4%, to $1.8 million, from $1.3 million in the six months ended June 30, 2009 primarily due to an increase from our education and training business, partly offset by a decrease from the retained search business. Contribution income as a percentage of other human capital management services revenue was 8.5% for the six months ended June 30, 2010 and 5.9% for the six months ended June 30, 2009, reflecting improved leverage in our education and training business, partially offset by negative operating leverage in our retained search business.
Depreciation and amortization expense
Depreciation and amortization expense in the six months ended June 30, 2010, totaled $6.3 million as compared to $6.7 million for the six months ended June 30, 2009. As a percentage of revenue, depreciation and amortization expense was 2.6% for the six months ended June 30, 2010 and 2.1% for the six months ended June 30, 2009.
20
Interest expense, net
Interest expense, net, totaled $2.2 million for the six months ended June 30, 2010 and $3.2 million for the six months ended June 30, 2009. The decrease in interest expense was due to lower average borrowings in the six months ended June 30, 2010, partially offset by a higher average effective interest rate on our borrowings. The effective interest rate on our borrowings was 5.7% for the six month period ended June 30, 2010 and 4.4% for the six month period ended June 30, 2009.
Income tax expense
Income tax expense totaled $1.3 million for the six months ended June 30, 2010, as compared to $3.1 million for the six months ended June 30, 2009. The effective tax rate was 35.4% in the six months ended June 30, 2010, compared to 36.8% in the six months ended June 30, 2009. The lower tax rate in the first half of 2010 was due to certain discrete items, including an immaterial prior year correction related to a tax election we made on behalf of a subsidiary we acquired in 2008 as part of the MDA acquisition. Excluding these items, the effective tax rate in the six months ended June 30, 2010 was 38.7%.
Liquidity and Capital Resources
As of June 30, 2010, we had a current ratio, defined as the amount of current assets divided by current liabilities, of 2.7 to 1. Working capital decreased by $11.4 million to $60.3 million as of June 30, 2010, compared to $71.7 million as of December 31, 2009. The decrease in working capital was primarily due to a decrease in accounts receivable and income taxes receivable. In April 2010, we received a federal tax refund of $5.6 million substantially related to our election, under the Worker, Homeownership, and Business Assistance Act of 2009, of a five year carryback period for our 2009 taxable net operating loss. This cash, along with cash on hand was used to repay our remaining earnout obligation for our acquisition of MDA.
Net cash provided by operating activities during the six months ended June 30, 2010, was $23.7 million, compared to $50.5 million in the six months ended June 30, 2009. The decrease is primarily due to lower collections of accounts receivable in the six months ended June 30, 2010 compared to the six months ended June 30, 2009, primarily due to declining revenues since December 2008. Number of days sales outstanding decreased by 2 days to 50 days at June 30, 2010, compared to 52 days at December 31, 2009.
Investing activities used $13.5 million in the six months ended June 30, 2010, compared to $9.2 million in the six months ended June 30, 2009. In the six months ended June 30, 2010, we used $12.8 million to pay the final earnout payment due on the MDA acquisition based on 2009 performance. In the six months ended June 30, 2009, we used $6.7 million to pay the earnout payment related to 2008 performance on our MDA acquisition. An additional $0.8 million was used primarily to pay the final earnout related to our acquisition of AKOS Ltd. and as well as other acquisition related payments related to MDA. Investing activities also used $0.7 million and $1.6 million, respectively, in cash, during the six months ended June 30, 2010 and 2009, for capital expenditures.
Net cash used in financing activities during the six months ended June 30, 2010, was $8.3 million compared to $40.1 million during the six months ended June 30, 2009. We repaid, in the six months ended June 30, 2010, a net of $6.6 million on our total debt, compared to a net of $40.2 million in the six months ended June 30, 2009. In addition, in the six months ended June 30, 2010, we paid $1.5 million in debt issuance costs to amend our current Credit Agreement, as discussed in the Credit Facility section. Both periods also included any cash flows relating to the vesting and exercise of share-based payments.
Stockholders Equity
During the six months ended June 30, 2010 and 2009, we were restricted under our Credit Agreement and we did not make any repurchases of shares of our common stock. Under the remainder of the February 2008 authorization, we can purchase up to an additional 1,441,139 shares, subject to the constraints of the Credit Agreement. At June 30, 2010, we had approximately 31.1 million shares of common stock outstanding.
On May 5, 2010, our shareholders approved an amendment to its 2007 Stock Incentive Plan (Plan) to: (1) increase the number of shares of common stock, par value $0.0001 per share (Common Stock), of the Company that may be issued under the Plan from 1,500,000 shares to 3,500,000 shares and (2) increase the share sub-limit for awards that are not stock appreciation awards that may be granted pursuant to the Plan from 1,200,000 shares to 1,700,000 shares of Common Stock.
21
On June 1, 2010, 205,647 shares of restricted stock at a market price of $8.09 were granted to directors and key employees. In addition, 254,000 stock appreciation rights were granted to key employees at a price of $8.09 and weighted average valuation per share of $2.77. Similar to prior grants, the restricted stock vests ratably over a four year period on the anniversary date of the grant. The stock appreciation rights vest 25% per year over a four year period, expire after seven years and can only be settled with stock.
Credit Facility
Our senior secured revolving credit facility entered into on November 10, 2005 was amended and restated as of September 9, 2008 (Credit Agreement) in connection with the acquisition of MDA. The Credit Agreement kept in place an existing $75.0 million revolving credit facility, maturing in November 2010, and provided for a 5-year $125.0 million term loan facility with Wachovia Capital Markets, LLC and certain of its affiliates, Banc of America Securities LLC and certain other lenders.
On May 28, 2010, we entered into a first amendment to our Credit Agreement with the lenders party thereto and Wells Fargo Bank, National Association (successor by merger to Wachovia Bank, National Association) as Administrative Agent. The Credit Agreement amendment, among other things, extends the maturity date of the revolving credit facility from November 2010 to September 2013, to be coterminous with the term loan, and reduces the existing revolving credit facility to $50.0 million, and the sublimit for letters of credit to $20.0 million. We paid $1.5 million of financing fees related to this amendment, that have been capitalized as debt issuance costs on the condensed consolidated balance sheet as of June 30, 2010. Debt issuance costs related to this amendment are being amortized on a straight-line basis over the remaining term of the Credit Agreement. In addition, we wrote off an immaterial amount of debt issuance costs related to the reduction of the size of the revolving credit facility.
In addition to the above mentioned changes, the terms of the Credit Agreement were adjusted to reflect customary covenants for similarly leveraged deals. As of June 30, 2010, interest on our revolving credit facility was based on LIBOR plus a margin of 3.50% or Base Rate (as defined by the Credit Agreement) plus a margin of 2.50%. The Company is required to pay a quarterly commitment fee on the average daily unused portion of the revolving loan facility, which, as of June 30, 2010 was 0.625%. The interest rate spreads on our term loans remained unchanged, and as of June 30, 2010 were based on LIBOR plus a margin of 2.00% or Base Rate plus a margin of 1.00%.
The table below summarizes what we believe are the key financial covenants, as defined by the Credit Agreement, as amended, and its corresponding actual performance as of June 30, 2010.
|
| Requirement |
| Actual |
Maximum Permitted Leverage Ratio (a) |
| 2.50 to 1.00 |
| 2.00 to 1.00 |
|
|
|
|
|
Minimum Fixed Charge Coverage Ratio (b) |
| 1.75 to 1.00 |
| 10.42 to 1.00 |
|
|
|
|
|
Maximum Capital Expenditures for 2010 (c) |
| $16.5 million |
| $0.7 million |
(a)
Our Leverage Ratio must not be greater than 2.50 to 1.00 for the duration of the Credit Agreement, September 2013.
(b)
Our Fixed Charge Coverage Ratio (as defined by the Credit Agreement) must not be less than: 1) 1.75 to 1.00 through December 31, 2010; 2) 1.50 to 1.00 for the fiscal year 2011; 3) 1.25 to 1.00 for the fiscal year 2012 and 4) 1.15 to 1.00 thereafter.
(c)
Aggregate amount of Capital Expenditures in any fiscal year may not exceed: 1) $4.0 million in the fiscal year 2010; 2) $5.0 million in the fiscal year 2011; and $7.0 million in the fiscal year 2012. However, the limit may be increased in any fiscal year by the amount of Capital Expenditures that were permitted but not made in the immediately preceding fiscal year, which is included in the table above.
22
Effective with the May 2010 amendment, the limitation on our ability to repurchase our common stock and declare and pay cash dividends on our common stock has been adjusted. The Credit Agreement, as amended, provides for an amount allowed for stock repurchases/dividends subsequent to May 28, 2010, that is the lesser of $25.0 million and 50% of cumulative Consolidated Net Income (as defined by the Credit Agreement) for each fiscal quarter after March 31, 2010 where financial statements have been delivered; provided, that the Companys Debt/EBITDA ratio (as defined by the Credit Agreement), after giving effect to the transaction, is less than 1.00 to 1.00 and there is $40.0 million in cash or available cash under its revolving loan facility. However, if the Companys Debt/EBITDA ratio , after giving effect to the transaction is less than 2.00 to 1.00 but equal to or greater than 1.00 to 1.00, and there are no amounts outstanding under the revolving credit facility (other than letters of credit), the allowable amount for repurchases/dividends is $2.5 million. Our requirement to obtain lender consent for acquisitions has also been adjusted. Effective with the May 2010 amendment, we are required to obtain the consent of our lenders to complete any acquisition which exceeds $20.0 million or would cause us to exceed $50.0 million in aggregate cash and non-cash consideration for Permitted Acquisitions (as defined by the Credit Agreement) during the term of the Credit Agreement (excluding the MDA acquisition).
Commitments and Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements.
The following table reflects our contractual obligations and other commitments as of June 30, 2010:
Commitments |
| Total |
| 2010 |
| 2011 |
| 2012 |
| 2013 |
| 2014 |
| Thereafter |
| |||||||
|
| (Amounts in thousands) |
| |||||||||||||||||||
Senior secured credit facility (a) |
| $ | 55,769 |
| $ | 2,730 |
| $ | 7,800 |
| $ | 18,330 |
| $ | 26,909 |
| $ | |
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital lease obligations |
|
| 581 |
|
| 107 |
|
| 158 |
|
| 143 |
|
| 154 |
|
| 19 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating leases obligations (b) |
|
| 29,767 |
|
| 3,329 |
|
| 6,224 |
|
| 5,718 |
|
| 5,003 |
|
| 2,938 |
|
| 6,555 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase obligations (c) |
|
| 976 |
|
| 440 |
|
| 485 |
|
| 51 |
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal settlement (d) |
|
| 345 |
|
| |
|
| 345 |
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| $ | 87,438 |
| $ | 6,606 |
| $ | 15,012 |
| $ | 24,242 |
| $ | 32,066 |
| $ | 2,957 |
| $ | 6,555 |
|
(a)
Under our Credit Agreement, we are required to comply with certain financial covenants. Our inability to comply with the required covenants or other provisions could result in default under our Credit Agreement. In the event of any such default and our inability to obtain a waiver of the default, all amounts outstanding under the Credit Agreement could be declared immediately due and payable.
(b)
Represents future minimum lease payments associated with operating lease agreements with original terms of more than one year.
(c)
Other contractual obligations include contracts for information systems, maintenance and support, consulting and other services and application hosting.
(d)
During the fourth quarter of 2009, the Company reached an agreement in principle to settle a class action lawsuit, Maureen Petray and Carina Higareda v. MedStaff, Inc., which settlement remains subject to court approval. In the fourth quarter of 2009, the Company accrued a pre-tax charge of $0.3 million ($0.2 million after taxes) related to this lawsuit. We expect the settlement to occur in 2011.
In July 2010, we entered into an agreement to lease 18,000 square feet of space in Pune, India for our in-house information systems and development support services as well as back-office processing services. The agreement is for three years with an option to extend for another two year period. The commitment is to pay approximately $0.2 million per year, with a total commitment of approximately $0.7 million. The commencement of the lease will be September 1, 2010.
In July 2010, we renegotiated our lease in Malden, Massachusetts. The new lease, effective July 1, 2010, reduces the space we occupy from approximately 31,662 square feet to approximately 22,767 square feet. In addition, the lease expiration was extended from June 30, 2012 to June 30, 2017, with an option to extend another three years. The revised lease has the effect of reducing our lease payment commitments by $0.2 million through June 30, 2012. However, the extension through 2017 added $1.3 million to our total commitment related to this property.
23
Critical Accounting Principles and Estimates
Our critical accounting principles remain consistent with those reported in our Annual Report on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission.
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The following discussion supplements the detailed information presented in our Annual Report on Form 10-K filed for the year ended December 31, 2009.
Our term loan bears interest at a rate of, at our option, either: (i) LIBOR plus a leverage-based margin or (ii) Base Rate plus a leverage-based margin. Excluding the impact of our interest rate swap agreements, a 1% change in interest rates would have resulted in interest expense fluctuating $0.3 million and $0.6 million in the six months ended June 30, 2010 and 2009, respectively. Considering the effect of our interest rate swap agreements a 1% change in interest rates on our variable rate debt would have resulted in interest expense fluctuating approximately $0.2 million the six months ended June 30, 2009. A 1% change in interest expense considering the effects of the interest rate swap agreements in the six months ended June 30, 2010 would be immaterial.
ITEM 4.
The Company carried out an evaluation, under the supervision and with the participation of the Companys Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this report. Based upon the evaluation, the Companys Chief Executive Officer and Chief Financial Officer concluded that the Companys disclosure controls and procedures are effective. Disclosure controls and procedures are designed to ensure that information required to be disclosed in Company reports filed or submitted under the Exchange Act is recorded, processed, summarized, communicated to management, including the Chief Executive Officer and the Chief Financial Officer, and reported within the time periods specified in the Securities and Exchange Commissions rules and forms. The disclosure controls and procedures are designed to ensure that information required to be disclosed by us in reports required under the Exchange Act of 1934, as amended, is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, in order to allow timely decisions regarding any required disclosure.
The evaluation has not identified any changes in the Companys internal controls over financial reporting or in other factors that occurred during the last fiscal quarter that have materially affected or that are reasonably likely to materially affect the Companys internal control over financial reporting.
24
ITEM 1.
Maureen Petray and Carina Higareda v. MedStaff, Inc
On February 18, 2005, the Companys MedStaff subsidiary became the subject of a purported class action lawsuit (Maureen Petray and Carina Higareda v. MedStaff, Inc.) filed in the Superior Court of California in Riverside County. The lawsuit relates to only MedStaff corporate employees working in California. The claims alleged under this lawsuit are generally similar in nature to those brought by Darrelyn Renee Henry in a lawsuit against the Company, which was dismissed (Darrelyn Renee Henry vs. MedStaff, Inc., et. al.).
The lawsuit alleges, among other things, violations of certain sections of the California Labor Code, the California Business and Professions Code, and recovery of unpaid wages and penalties. MedStaff currently has less than 50 corporate employees in California. The Plaintiffs, Maureen Petray and Carina Higareda, purport to sue on behalf of themselves and all others similarly situated, and allege that MedStaff failed, under California law, to provide corporate employees while in on-call status with meal periods and rest breaks, and pay for those missed meal periods and rest breaks; failed to compensate the employees for all hours worked; failed to compensate the employees for working overtime; failed to keep appropriate records to keep track of time worked; failed to pay Plaintiffs and their purported class as required by law. Plaintiffs seek, among other things, an order enjoining MedStaff from engaging in the practices challenged in the com plaint and for full restitution of all monies, for interest, for certain penalties provided for by the California Labor Code and for attorneys fees and costs. On February 5, 2007, the court granted class certification. On October 16, 2008, MedStaff filed a Motion to Decertify the class which was denied on December 19, 2008. Trial was scheduled to occur in the second quarter of 2010; however, in December 2009, the Company reached an agreement in principle to settle this matter. As a result, the Company accrued a pre-tax charge of $345,000 (approximately $209,000 after taxes) related to this lawsuit. The final settlement agreement will be subject to court approval.
The Company is also subject to other legal proceedings and claims that arise in the ordinary course of its business. In the opinion of management, the outcome of these other matters will not have a significant effect on the Companys consolidated financial position or results of operations.
ITEM 1A.
There are no material changes to our Risk Factors as previously disclosed in our Form 10-K for the year ended December 31, 2009.
ITEM 6.
See Exhibit Index immediately following signature page.
25
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
| CROSS COUNTRY HEALTHCARE, INC. | |
|
|
|
|
|
Date: | August 5, 2010 |
| By: | /s/ EMIL HENSEL |
|
|
|
| Emil Hensel Chief Financial Officer and Director (Principal Financial Officer) |
|
|
|
|
|
|
|
|
|
|
Date: | August 5, 2010 |
| By: | /s/ DANIEL J. LEWIS |
|
|
|
| Daniel J. Lewis Chief Accounting Officer (Principal Accounting Officer) |
26
EXHIBIT INDEX
No. |
| Description |
| Lease Agreement, dated July 1, 2010, between Goldberg Brothers Real Estate LLC and MCVT, Inc. | |
| Leave and License Agreement, dated July 28, 2010, between Subhash Gaikwad, Hindu Undivided Family and Crosscountry Infotech Pvt. Ltd. | |
| Certification pursuant to Rule 13a-14(a) and Rule 15d-14 (a) by Joseph A. Boshart, President and Chief Executive Officer | |
|
|
|
| Certification pursuant to Rule 13a-14(a) and Rule 15d-14 (a) by Emil Hensel, Chief Financial Officer | |
|
|
|
| Certification pursuant to 18 U.S.C. Section 1350 by Joseph A. Boshart, Chief Executive Officer | |
|
|
|
| Certification pursuant to 18 U.S.C. Section 1350 by Emil Hensel, Chief Financial Officer |
27
Unit | Square footage | |
F-104a | 1,262 +/- Sq Ft | Computer use |
S-201 | 10,051 +/- Sq Ft | Office use |
T-301 | 10,051 +/- Sq Ft | Office use |
B-101 | 1,200 +/- Sq Ft | Storage use |
BB-101 | 203 +/- Sq Ft | Storage use |
|
Monthly
|
|
Annually
|
|||||
07/01/10 - 06/30/11
|
$
|
25,017.70
|
$
|
300,212.40
|
||||
07/01/11 - 06/30/12
|
$
|
25,017.70
|
$
|
300,212.40
|
||||
07/01/12 - 06/30/13
|
$
|
25,017.70
|
$
|
300,212.40
|
||||
07/01/13 - 06/30/14
|
$
|
25,017.70
|
$
|
300,212.40
|
||||
07/01/14 - 06/30/15
|
$
|
25,017.70
|
$
|
300,212.40
|
||||
07/01/15 - 06/30/16
|
$
|
27,533.08
|
$
|
330,396.97
|
||||
07/01/16 - 06/30/17
|
$
|
27,533.08
|
$
|
330,396.97
|
||||
Lease Term Total Base Rent:
|
$
|
2,161,185.93
|
||||||
Sq Ft
|
|
Type
|
|
Rent PSF
|
|
Mo. Rent
|
|
Yearly Rent
|
||||||
20,102
|
office
|
$
|
13.4930
|
$
|
22,603.02
|
$
|
271,236.29
|
|||||||
1,262
|
Computer
|
$
|
13.4930
|
$
|
1,419.01
|
$
|
17,028.17
|
|||||||
1,403
|
Storage
|
$
|
8.5160
|
$
|
995.67
|
$
|
11,948.00
|
|||||||
$
|
25,017.70
|
$
|
300,212.40
|
|
A:
|
Tenant sends and Landlord receives "in hand" on or before 5:00 PM October 1 2016 written notice via certified mail, return receipt requested or by nationally-recognized overnight delivery service providing a receipt for delivery, a notice evidencing Tenant’s intent to exercise Tenant’s right to extend the Lease Term for the Option Period.
|
|
B:
|
At the time of exercising this option, Tenant must be in conformance and in good standing in all material aspects, obligations and conditions under this lease.
|
|
C:
|
During the Option Period, all terms, covenants, conditions and provisions of this Lease shall remain in full effect and force except Tenant’s Monthly Base Rent during this Option Period shall be the then "Current Market Rent" for the Leased Premises less five (5.00%) percent.
|
|
a:
|
Empty all trash receptacles. Change liners as necessary.
|
|
b:
|
Wipe and dust all furniture surfaces.
|
|
c:
|
Vacuum all carpet surfaces, paying particular attention to corners edges and under exposed furnishings.
|
|
d:
|
Sweep and vacuum all non-carpeted floors.
|
|
e:
|
Wipe down all finger prints off doors and door frames.
|
|
f:
|
Remove Rubbish to designated disposal area.
|
|
a:
|
Wipe down all tables and chairs.
|
|
b:
|
Wipe down all cabinets and counters.
|
|
c:
|
Clean sink area.
|
|
d:
|
Wipe down all appliances, including the interior of microwave.
|
|
e:
|
Sweep and wash flooring.
|
|
a:
|
Clean and disinfect all bathroom fixtures.
|
|
b:
|
Replenish supplies (paper towels, toilet paper, soap, etc.)
|
|
c:
|
Wipe down walls and paper dispensers.
|
|
d:
|
Sweep and wash flooring using a disinfectant solution.
|
|
e:
|
Empty all waste receptacles, change liners daily.
|
|
f:
|
Clean and polish all mirrors and bright work.
|
|
a:
|
Wash all non-carpeted flooring. Tenant is responsible to remove all paper products and/or other belongings that could be reasonably determined to be damaged if the Cleaning Service washes and/or waxes Tenant's "Mail room" flooring.
|
|
b:
|
Wipe and clean all glass wall inserts.
|
|
c:
|
Police/clean debris from rear lot and front sidewalk.
|
|
a:
|
Wax all non-carpet floor areas:
|
|
a:
|
Vacuum all ceiling vents.
|
|
b:
|
Dust all ceiling light fixtures.
|
|
A.
|
To conduct Tenant's business at all times in a professional and reputable manner.
|
|
B.
|
To comply with all governmental rules and regulations related to the storage and disposal of refuse; to store all trash and refuse within the Leased Premises or within the dumpster located in the rear parking lot area of the Property.
|
|
|
C.
|
Not to use the Leased Premises in a manner which shall be unlawful, improper, noisy, odorous or offensive to the other Tenants within the Building and not to use the Leased Premises in any way that shall be contrary to any law or any municipal by-law of the City of Malden. Tenant agrees that Landlord has made no representation or warranties with respect to the Tenant's intended use of the leased premises.
|
|
D.
|
To comply promptly with all applicable laws, rules, regulations, ordinances, requirements, or orders of public authorities, the Board of Fire Underwriters, and similar organizations except when the Landlord is responsible for compliance therewith under the terms and conditions of this Lease.
|
|
E.
|
Not to make any use of the Leased Premises which shall invalidate or increase the cost of the Landlord's insurance, nor use any advertising medium which may constitute a nuisance; nor do any act tending to injure the reputation of the property.
|
|
F.
|
To be responsible for all maintenance and repairs within the interior of the Leased Premises. Landlord shall be responsible for structural repairs and any equipment that is the Landlord's obligation to maintain pursuant to Section # 14. Tenant's responsibility shall include without limitation, electrical, plumbing, windows, doors, and any interior improvements serving the Leased Premises exclusively. At the end of Tenant's occupancy, Tenant shall surrender the Leased Premises in the same condition as at the commencement of Tenant’s occupancy, reasonable wear and tear only excepted.
|
|
G.
|
Not to overload or deface the Leased Premises.
|
|
H.
|
To save harmless and to indemnify Landlord from and against any and all liability, costs and expenses for damages, losses, injuries, or death to persons or losses to property as a result of Tenant's occupation of the Leased Premises excepting only those arising from any omission, negligence or willful misconduct of Landlord or its employees, vendors, other Tenant’s or Agents, such indemnification to include Landlord's reasonable attorney's fees and costs. Tenant agrees to maintain commercial general liability insurance on the Leased Premises protecting both Landlord and the Tenant, and shall furnish the Landlord a certificate showing such to Landlord on an annual basis a certificate showing such insurance to be in force. The amount of such public liability insurance shall be a minimum of $1,000,000.00 dollars per occurrence and
$2,000,000.00 in the aggregate.
|
|
In addition, Landlord recommends this policy have a plate glass and door endorsement, for the Tenant is responsible for repairing and replacing any broken glass, doors and frames within or providing access to the Leased Premises which for any reason may occur other than by Landlord's fault.
|
|
I.
|
To understand and agree Tenant's furnishings, fixtures, equipment, effects, and property of every kind, in the Building shall be at the sole risk and hazard of Tenant. If all or any part thereof shall be destroyed or damaged by fire, water, or any other casualty, or by leakage or bursting of water pipes, or any other pipes, by theft or from other cause, no part of such loss is to be charged to or be borne by Landlord unless such damage was caused by the negligence or willful misconduct of Landlord.
|
|
J.
|
Not assign this lease, nor sublet in whole or any portion of the Leased Premises, nor permit the use of all or any part of the Leased Premises by persons other than the Tenant, its servants and agents, without the written consent of the Landlord. Any such assignment, sublease or permission to occupy without such consent shall be a material breach of this Lease by Tenant, and at the option of the Landlord, entitle Landlord to terminate this Lease. Landlord's permission to assign, sublease or permit occupancy of the Leased Premises by others shall not be unreasonably withheld or delayed.
|
|
K.
|
Not to make any alterations, installations, (other than trade fixtures) or additions to the Leased Premises, nor permit the painting, or placing of signs, awnings, flagpoles, or various types of advertisement media or the like in, or about the Leased Premises, without on each occasion obtaining the prior written permission of Landlord, which shall not be unreasonably withheld or delayed.
|
|
L.
|
To pay promptly when due, excluding the $12,000.00 credit provided by Landlord, the entire cost of any alterations or improvements, including the lobby area sight window, painting of lobby area walls and common area directory signage, in the Leased Premises undertaken by Tenant and to bond against or discharge any liens for labor or materials in connection therewith within thirty (30) days after a request by Landlord; to procure all necessary permits before undertaking such work; and to do all such work in a good and workmanlike manner, employing materials equal in quality to those used in Landlord's work and to comply with all governmental requirements in connection with such improvements.
|
|
M.
|
To discharge (by payment or by filing of the necessary bond or otherwise) any mechanics, materialman's or other liens against the Leased Premises or the Landlord’s interest therein, which liens may arise out of any payments due, or purported to be due, for any labor, services, materials, supplies, or equipment alleged to have been furnished to or at the request of Tenant in, upon, or about the leased premises.
|
|
N.
|
Upon Landlord providing Tenant reasonable oral notice (not less than 24 hours in advance),to permit Landlord during business hours to enter to view the Leased Premises or to show the same to prospective purchasers, lenders, Tenants, agents of Landlord, or repair personal. If an emergency arises, in Landlord's reasonable determination, Landlord shall have the right of access at any time to rectify such emergency.
|
|
O.
|
To remove at the termination of this Lease or occupation of the Leased Premises, all Tenant’s goods and effects from the Leased Premises which are not the property of the Landlord, and to yield up to Landlord the Leased Premises with all keys and locks. The Leased Premises shall be in the same condition as at the commencement of this Lease or as altered/built out during the course of the Lease, reasonable wear and tear only excepted. Landlord shall have the right to treat any remaining property as abandoned and to dispose of such property at Tenant's expense in any manner the Landlord deems fit.
|
|
P.
|
To permit Landlord without molestation to install reasonable "for lease" sign(s) within Tenant's windows NINE (9) months prior to the end of the Lease Term. Landlord covenant's to remove said sign(s) upon Landlord’s leasing of the Leased Premises.
|
|
Q.
|
To pay when due all electricity separately metered to Leased Premises, telephone, and other charges payable on account of Tenant’s use of utilities in the Leased Premises.
|
12.
|
LANDLORD’S IMPROVEMENTS
|
|
1:
|
Contractor shall provide to Landlord prior to commencement of any work at the Property evidence of appropriate workman compensation insurance coverage and Liability Insurance Coverage (Minimum of One Million Dollars) by an Insurance Company licensed to provide such insurance within the Commonwealth of Massachusetts.
|
|
2:
|
Contractor shall only use materials equal to or that exceeds the quality of materials already in place. Contractor shall further make all reasonable efforts to match all existing materials in place.
|
Monday - Friday | 8:00 a.m. - 8:00 p.m. | |
Saturday | 8:00 a.m. - 2:00 p.m. | |
Sunday | None |
Alarm ON | Alarm OFF | ||
Monday | 9:30PM | 6:30AM | |
Tuesday | 9:30PM | 6:30AM | |
Wednesday | 9:30PM | 6:30AM | |
Thursday | 9:30PM | 6:30AM | |
Friday | 10:00PM | 6:30AM | |
Saturday | 7:00PM | 6:30AM | |
Sunday | 7:00PM | 6:30AM | |
|
B:
|
Existing Lease Agreement:
|
|
Landlord and Tenant’s existing Lease Agreement
|
|
dated March 30, 2004 shall continue in full
|
|
force and effect with respect to overage operating
|
|
and real estate charges Tenant owes Landlord
|
|
through December 31st 2010.
|
7/12/10 |
|
|
/s/ Edward R. Spadoni | |
Date |
Edward R. Spadoni as President
|
|||
For MCVT, Inc.
|
||||
7/16/10 |
|
|
/s/ Steven J. Goldberg | |
Date |
Steven J. Goldberg, Co-Manager,
|
|||
for the Goldberg Brothers Real Estate LLC
|
||||
7/15/10 |
|
|
/s/ William H. Goldberg | |
Date |
William H. Goldberg, Co-Manager,
|
|||
for the Goldberg Brothers Real Estate LLC
|
||||
|
(i)
|
The Licensor represented that it is owner and absolutely seized and possessed of or otherwise is well and sufficiently entitled as a lawful owner to give the commercial office space at Ground and 1st floor, of the Building “AG Inspire”, situated at survey no 126/2 Off. ITI Road, Aundh, Pune 411 007, admeasuring built-up area of 18,000 sq.ft.
|
|
(ii)
|
The Licensee is engaged in the business of Information Technology & Information Technology Enabled Services with due registration of Software Technology Parks of India.
|
|
(iii)
|
The Licensee has approached the Licensor with a request to allow the Licensee to use and occupy the said premise for carrying on its business, for a period of 60 Months (5 Years), on Leave and License basis, with a lock in period of 36 (thirty six) months.
|
(iv)
|
Licensor agrees to grant to the Licensee and Licensee accepts from the Licensors the License to enter upon, use, occupy, possess and enjoy the office premises situated at the Ground and 1stFloor of the building “AG Inspire”, situated at survey no 126/2 Off. ITI Road Aundh, Pune 411 007 totally admeasuring built-up area of 18,000 sq. ft. (herein after referred to as the “Licensed Premises”), which is more particularly described in the Schedule I of this Agreement and on the terms and conditions and for the consideration as mentioned herein under.
|
(v)
|
The Effective Date of this Leave and License agreement shall be 1st September 2010.
|
|
(i)
|
In consideration of the license fees hereby reserved and in further consideration of the covenant hereinafter contained on the part of the Licensee, to be paid, observed and performed, the Licensor hereby grants to the Licensee and the Licensee hereby accepts from the Licensor the license to use and occupy the Licensed Premises situated at Ground & 1st Floor in the building “AG Inspire”, survey no 126/2 Off. ITI Road, Aundh, Pune 411 007, admeasuring built-up area of 18,000 sq.ft. for a period of 5 Years, There will be a lock in period of 36 (thirty six) months effective 1st September 2010 to 31st August 2013 and either party shall not be entitled to terminate this License. On completion of the lock in period the licensee shall be entitled t
o terminate this agreement by giving a three month notice during the lock in period. The license to use the said licensed premises for additional period of 24 months will be at the sole option of the Licensee.
|
5.1
|
On and from the Commencement Date, the Licensee shall, in addition to the payments mentioned in clause 5.1, be liable to pay/ reimburse without delay and/or demur, all charges for electricity actually consumed in the Licensed Premises as per the bills sent by the Licensor to the Licensee in this regards based on the actual amount charged by the electricity authorities or received by the Licensee directly from the electricity company, as the case may be. In this regard the Licensor has provided a separate electric connection and electric meter in the Licensed Premises for the benefit and use of the Licensee and if at a future date any additional load /electricity connection is required by the Licensee the same will also be arranged by the Licensor at its own cost. It is hereby fully clarified that if any deposit or load charges or demand charges is payable for the existing electricity connection or for any future enhanced need of the Licensee commensurate with its business requirements, the same shall be fully borne by the Licensor and the Licensee shall be obligated to pay only the electricity charges as per its own consumption. The Licensee shall also, on and from the Commencement Date, be liable to pay / reimburse all the telephone bills in respect of the telephone (s), if any, installed and actually used by the Licensee in the Licensed Premises.
|
5.2
|
During the period of the agreement and any renewal thereof, Licensee shall, save as provided herein, not bear and pay any taxes and or outgoing payable in respect of the said premises and the Licensor shall pay all the Municipal taxes, ground rent, cesses, property tax, Duties and other outgoings due in respect of the said premises and all increases thereto arising during the period of the agreement or any renewal thereof. The Licensee shall not be required to make any such aforesaid payment. All applicable service taxes and any increase in the service taxes shall be borne by the Licensee.
|
5.3
|
The licensor shall provide 18 car parks and 90 two wheeler parks allotted to and specifically reserved for the Licensee in the building in which the Licensed Premises are situated, at no additional cost to the Licensee.
|
5.4
|
The licensor shall provide space for recreation like Table Tennis, Pool table etc on the terrace specially reserved for the Licensee in the building in which the Licensed Premises are situated at no additional cost to the Licensee.
|
5.5
|
The licensor shall provide space for cafeteria to seat 100 number of people on the terrace specially reserved for the Licensee in the building in which the Licensed Premises are situated at no additional cost to the Licensee.
|
5.6
|
There will be no extra maintenance charges which shall be payable by the licensee to the licensor.
|
6.
|
|
SECURITY DEPOSIT
|
|
●
|
On execution of this Agreement, the Licensee shall pay to the Licensor a sum of Rs. 60, 00,000/- (Rupees Sixty Lakhs only) as interest free security deposit.
|
|
●
|
The balance deposit amounting to Rs 30, 00,000 /-(Rupees Thirty lakhs only) shall be paid by the licensee to the licensor on 1st September or possession of the premise whichever is earlier.
|
6.2
|
The Licensee shall be fully entitled to bring in and install its furniture, fit outs and equipments in the Licensed Premises and on termination of this Agreement the Licensee shall remove all UPS, Server, Computers Hardware and Software, Computer Networking, EPBX, Telephone Instruments, Surveillance Systems and all other office Equipments belonging to the Licensee from the Licensed Premises (save and except all the furniture, fitting and fixtures, floorings, ceilings, Air Conditions, Electrical fittings and wiring/cabling which has been provided by the Licensor). It is hereby fully clarified that all Licensee made improvements and fit outs in the Licensed Premises shall be always owned by the Licensee and at the expiry or earlier termination of the License, the Licensee shall be fully entitled to remove and take away such imp
rovements and fit outs to the extent possible or otherwise deal with the same as long as the same does not cause any material damage to the Licensed Premises.
|
7.1
|
The Licensed Premises shall be utilized by the Licensee solely and exclusively for carrying on the business as aforesaid and for no other purpose whatsoever.
|
7.2
|
The Licensee shall carry on business only in their products/services/software/trade name as specified in clause 2 hereinabove and shall not carry on any other business or activity from the Licensed Premises throughout the License period.
|
7.3
|
The Licensee shall use the Licensed Premises for the purpose of carrying on the aforesaid business on all days on 24 X 7 days basis subject to the provisions of Shops and Establishment Act and Rules thereof or any other enactment / rules prevailing from time to time.
|
7.4
|
The Licensee shall pay to the Licensor the license fee as stipulated in clause 5.1 above promptly and on the respective due dates thereof and if the Licensee fails and neglects to pay the said Licensed fee on its due dates for a period of two consequent months in spite of a 30 days notice from the Licensor in that events the Licensor shall be entitled to deduct the outstanding License fee from the interest free security deposit and terminate this Agreement by giving one month’s notice to the Licensee.
|
7.4
|
The Licensee shall not do or suffer to be done anything in the Licensed Premises, which is or is likely to be a nuisance or annoyance to the other occupants of the neighboring premises or to prejudice the right of the Licensor as the owners of the Licensed Premises in any manner whatsoever. The Licensee shall not do or cause or allow or permit to be done in or around the Licensed Premises anything of an illegal or immoral nature.
|
7.6
|
The Licensee shall not store or allow being stored and/or displaying or selling in the Licensed Premises any goods, articles or things of a hazardous inflammable explosive corrosive toxic or combustible nature and / or any contraband goods.
|
7.7
|
The Licensee shall not do or suffer to be done anything whereby the Licensor’s right to hold the Licensed Premises is voided, forfeited or extinguished.
|
7.8
|
The Licensee shall pay the said License fee in advance to the Licensor on or before the 10th day of each calendar month. It is hereby agreed by the Licensee that in the event of Licensor’s arranging with any bank or financial institution for discounting the amount of License Fee receivable by it under this Agreement, the Licensee, upon receipt of instruction from the Licensor shall pay the amount of License Fee payable under this agreement to the Bank or Financial institution as the case may be as directed by the Licensor and the Licensor hereby confirms and agrees that such payment shall constitute a proper, valid and effective discharge of the Licensee’s obligations for payment of the License Fee to the extent of amount paid under this Agreement
.
|
7.9
|
The Licensee shall not transfer, assign or induct any third party or creates any third party interest in the Licensed Premises or any part or portion thereof. However, concurrent usage of the Licensed Premises by any group company shall not be treated as inducting a third party or creation of any third party interest.
|
7.11
|
The Licensee shall not make any structural alteration to the Licensed Premises and shall not make any construction or erection of a permanent nature in the Licensed Premises.
|
7.12
|
The Licensee shall not do or suffer to be done in or around or upon the Licensed Premises any act or omission, whereby any policy of insurance taken by the Licensor in respect of the Licensed Premises may become void or voidable or whereby the premium payable in respect thereof may be increased.
|
7.13
|
The Licensee shall during the License period, observe, perform, conform and comply strictly with the provisions hereof, the rules, regulations, enactments and bye-laws of the Municipal Corporation of Pune and / or reasonable bye-laws and rules and regulation that may be framed by the Society managing the affairs of the building in which the Licensed Premises are situated and which are conducive to the general administration of the Licensed Premises.
|
7.14
|
The Licensee shall remove itself and its permitted belongings as mentioned elsewhere in this Agreement, employees, staff, and agent and all other person from the Licensed Premises upon expiry or sooner determination of this Agreement.
|
7.15
|
In addition to the payment of the License Fee, the Licensee shall also be liable during the License period pay to the concerned authorities directly or reimburse the amount for the following charges based on actuals and on the proof of payment provided by the Licensor, the following:-
|
|
(a) Telephone charges and rental in respect of separate telephone lines, leased lines and any other telecom infrastructure either taken directly by the Licensee or provided by Licensor in the Licensed Premises;
|
|
(b) Electricity charges for the electricity consumed in the Licensed Premises in accordance with the electricity bills received for separate electricity meter provided by the Licensed Premises.
|
|
(c) Consumption charges for DG in accordance with the invoices raised by the Licensor.
|
7.16
|
The Licensee hereby covenants with the Licensor that it will obtain all necessary approvals/licenses and sanctions from the concerned authorities for carrying on its business and comply with all the conditions of such licenses/approvals/sanctions and take appropriate insurance policy and third party insurance at its own cost for furniture, fixtures, goods and articles belonging to the Licensee and lying in / brought in to the Licensed Premises. The claim shall lie with the Licensee till the expiration or termination of this Agreement. In the event the fitments and interiors provided by the Licensor are damaged due to any cause attributed to the Licensee (normal wear and tear excepted) during the Licensee period, the Licensee shall redo the interiors and fitments in the licensed premises.
|
7.17
|
The Licensee shall keep and maintain and use the Licensee premises in good order and condition except for reasonable wear and tear during the term of this Agreement.
|
7.18
|
The Licensee shall permit the Licensor, its agents, employees and/or authorized representative to enter upon the Licensed Premises for inspection and to carry out repair at reasonable time as and when necessary on giving two days advance notice in writing.
|
7.19
|
The Licensee undertakes not to provide any services for use of/by the Licensee in the Licensed Premises through the voids, conduits, outlets, etc, RCC works, staircases, terrace of the building, common areas, open compound, internal roads or any other spaces except for the earmarked areas (“Earmarked areas”) by the parties, for use of the Licensee. PROVIDED THAT if such permitted services shall, at no time, prejudicially affect the interest of the Licensor or any of the neighboring occupants. Provided however, the Licensee shall have the right to use and enjoy all common area, open compound, internal road, etc., available in the building in which the Licensed Premises are situated, in common with other occupants of the building.
|
7.21
|
The Licensee shall inform the Licensor in advance before any outside agency or any service provider providing services to the Licensee is required, to enter the building for maintenance of the Licensor property, in the building/common area.
|
7.22
|
The Licensee agree and confirm that the rights granted to the Licensee under this Agreement is limited and restricted to use of the Licensed Premises only and the Licensee is not in any manner concerned with the balance area in the building, except use of common facilities and amenities in common with other occupants of the building.
|
7.23
|
The Licensee will observe and perform following terms and conditions.
|
|
a. Not to make use of the permit or allow its servants or agents to make use of any space in the said building other than Licensed Premises including the Earmarked areas and common facilities and amenities available for use for all occupants of the building in common.
|
|
b. Not to do or permit its servants or agents to do anything causing nuisance or annoyance to the other occupants of the said building.
|
|
c. To employ and engage as its own employee or subcontractors for running the Licensed Premises and to pay their wages and salaries promptly.
|
|
d. To ensure that all persons employed behave in an orderly and disciplined manner and that the said employees are prohibited from carrying any unfair activities in the Licensed Premises and/or within the said building and / or in the vicinity of the said building.
|
|
e. To ensure that neither the Licensee nor its employee shall enter any other portion of the said building except the Licensed Premises and such portions as are required as a means of ingress and egress to the Licensed Premises provided therefore and other Earmarked areas and common places.
|
|
f. The Licensee and its staff shall not do any act which may cause nuisance or annoyance to the Licensor or other occupants of the neighboring premises or its customers.
|
|
g. The Licensee shall not affix or exhibit any other signage on the exterior of the Licensed Premises other than the earmarked space without the written permission of the Licensor.
|
|
h. To keep the Licensed Premises clean and respectable.
|
8.1
|
The Licensor hereby confirms that save and except creating security by way of mortgage / charges in or upon the said licensed premises in favour of Bank / Financial Institution for raising finance, the Licensor has not created any third party interest in the Licensed Premises. In the event the Licensor defaults the payments of such mortgage, the Licensor shall indemnify and hold harmless the Licensee and shall safeguard all the rights of the Licensee, till the term of this Agreement including extensions if any.
|
8.2
|
Notwithstanding anything contained in this Agreement, the parties hereto expressly agree and declare that the Licensor shall be entitled at its discretion to sell and / or otherwise dispose of the Licensed Premises or any portion thereof during the subsistence of this Agreement to any third party whomsoever with a prior written notice of a period of 60 (Sixty) days to the Licensee. Provided however that such third party enters into an identical agreement with the Licensee for the remainder of the License period of this Agreement and the rights of the Licensee are not affected in any manner.
|
8.3
|
That the Licensor represents and warrants that it is a lawful owner and titleholder of the Licensed Premises and is fully empowered, authorized and able to execute this Leave and License Agreement.
|
8.4
|
That the Licensor represents and warrants that the Licensed Premises including the building in which the Licensed Premises are situated having constructed strictly as per the approved plan of Municipal Authorities / Town Planning bodies in Pune and there is no deviation or violation of such approved / sanctioned plan. Besides, all necessary permissions and approvals in respect of constructing, using and occupying the building in which the Licensed Premises are situated have been duly obtained and the terms and conditions stipulated therein have been and is being duly complied with.
|
8.5
|
That the Licensee shall be fully able to access the Licensed Premises from the main road and approach road connecting the building with the main road, without any let, hindrance, obstruction or objection of whatsoever nature from anybody.
|
8. 6
|
The Licensor covenants that upon the Licensee paying the License fee herein reserved and all other payments and observing and performing the terms and conditions on the Licensees part herein contained, the Licensee shall be entitled to peaceful and quiet use and enjoyment of the Licensed Premises during the period of the License free from any interference, objection, evictions, claim, interruptions and demand whatsoever by the Licensor.
|
8.7
|
The Licensor by way of this Agreement grants to the Licensee the right of way to the Licensed Premises and all other Earmarked areas and access to the other common areas of the premises for use of the same in common with other occupants.
|
8.8
|
The Licensor shall fully insure the Licensed Premises and the building along with all furniture and fixtures provided by the Licensor thereon against fire and other natural calamities and may provide proof of such insurance policies to the Licensee.
|
8.9
|
For the purpose of its business, the Licensee shall be required to install communication tower, dish antenna, equipment, etc., at the terrace of the building. The Licensor shall ensure that the Licensee is able to do so and if any permission in this regard is necessary from the society formed for the building or anybody else connected with the building, the Licensor shall obtain the said permission for the Licensee and also provide all such documents and papers which are required by the Licensee for installation of such communication tower, etc.
|
8.10
|
The Licensee shall be conducting its business in the Licensed Premises in the field of Information Technology Enabled Services and BPO activities under the STP Scheme of Government of India. Therefore the Licensee shall be fully entitled to register the Licensed Premises with STPI under STP Scheme and bond the Licensed Premises with the customs authorities and the Licensor or anybody connected with the Licensed Premises shall not have any objection whatsoever in this regard and shall provide all necessary documents, papers, no objection letters, etc., to the Licensee.
|
9.1
|
In the event of the Licensee committing a breach of any of the terms of this Agreement and failing, within 60 days, to remedy or make good such breach on receipt of notice in writing from the Licensor, the Licensor shall be entitled to forthwith terminate this Agreement and to refund the balance amount of the interest free security deposit ,after deducting any outstanding due from the Licensee for which consequences along with outstanding maintenance charges, Electricity charges, Telephone charges and interest @ 12% p .a on said amount, or any part thereof without prejudice to any other rights or remedies which the Licensor may have under the License Agreement or under any other Agreement or under law and in such event the consequences stipulated in clause 9.3, shall apply.
|
9.2
|
The Licensee may after the lock in period of 36 months terminate this agreement by giving to the Licensor 3 (Three) month’s written notice of their intention to terminate this agreement. Upon the expiry of the said period of three months, the Licensee shall vacate the said licensed premises as stipulated elsewhere in this Agreement on receipt of refund of the security deposit from the Licensor and if the Licensor fails to refund the security deposit simultaneously at the time of Licensee prepared to vacate the Licensed Premises, the consequences detailed herein above in Clause 6.1 for non-refund of security deposit by the Licensor, shall automatically ensue.
|
9.3
|
Upon termination of the Agreement as mentioned hereinabove or sooner determination of this Agreement for any reason whatsoever.
|
|
(a) The Licensee shall remove or cause to be removed itself, its agents and all its employees and all other person or persons and their respective belongings, chattels, articles and things from the Licensed Premises and shall hand over to the Licensor, on simultaneously receiving the refund of the security deposit from the Licensor, vacant, quiet, peaceful and furnished possession of the Licensed Premises together with the furniture, fittings and fixtures provided by the Licensor in good condition, except normal wear and tear.
|
|
(b) Without prejudice to any other rights or remedies with the Licensor may have under this Agreement or under any other Agreement with the Licensee or under laws or otherwise howsoever including the right to recover the Licensed Premises as aforesaid and in addition there to, until such time as the Licensee or any of its employees or its servants and / or agents or any other person as aforesaid shall use and occupy the Licensed Premises or any part thereof after expiration or sooner determination of this License and such use and occupation of Licensee is not due to failure on the part of the Licensor to refund the security deposit of the Licensee, the Licensee shall, over and above the License Fee stated in clause 5 above, be liable to pay to the Licensor, one time the monthly License fee per day calculated
prorata until the Licensee vacate the Licensed Premises as aforesaid as and by way of Liquidized damages and not by way of penalty.
|
|
(c) In the event of failure and/or neglect on the part of the Licensor to refund the interest free deposit, against the Licensee vacating the Licensed Premises by itself and/or by its agents/servants and employees, the Licensee shall be entitled to receive interest calculable @ 12% p.a on the amounts to be refunded by the Licensor to the Licensee from the date it became refundable till the date of refund and the same shall be in addition to the right of the Licensee as provided under Clause 6.1 herein above.
|
10.1
|
The use and occupation by the Licensee of the Licensed Premises is confined only to the Licensed Premises and neither amounts to nor is it intended to create any tenancy, sub-tenancy rights or as transferring any rights, title and interest of any nature whatsoever in favour of the Licensee in, over or upon the Licensed Premises or any part or parts thereof, save group companies, subsidiaries and affiliates.
|
10.2
|
At no point of time, irrespective of any change in law, the Licensee will claim and, or anyone on behalf of the Licensee contained that this Agreement or the use and occupation of the Licensed Premises amounts to create on lease, tenancy or sub-tenancy rights or creates or transfers any right title, interest, easement of any nature whatsoever in favour of the Licensee in, over or upon the Licensed premises of any parts thereof.
|
10.3
|
The Licensed premises is given to the Licensee on a Leave and License basis and the Licensee will not be entitled to transfer the benefits of this Agreement to anybody else or will not be entitled to allow anybody else and / or any other person or entity to occupy the Licensed Premises or any part thereof, save group companies, subsidiaries and affiliates.
|
10.4
|
It is expressly agreed by and between the parties hereto that the License fee payable by the Licensee to the Licensor shall for all purposes be deemed to be the fair and reasonable License fee and the Licensee shall not under any circumstances challenge the same in any court of law or any other authority or tribunal or forum as not being fair License fee in respect of the License herein granted of the Licensed Premises.
|
10.5
|
If as a result of any legislation, the Licensee becomes entitled to continue the use or occupation of the Licensed Premises against the will or desire of the Licensor or if any of the rights, powers or privileges of the Licensor becomes incapable of legal recognition or enforcement in their entirety, in such event, the Licensee shall not take advantage of such legislation and shall continue to use the Licensed premises in accordance with this Agreement and the provisions of such legislation shall, so far they are inconsistent with the provisions of this Agreement, be deemed to have been waived by the Licensee.
|
11.1
|
Any notice required to be served upon the Licensee shall be sufficiently served upon if posted by Registered A/D post or hand-delivered to the Licensee in the Licensed Premises on taking proper acknowledgement with a copy to the parent company of the Licensee M/s. Cross Country Healthcare Inc at 6551 Park of Commerce Blvd, NW Boca Raton, Florida 33487, USA by fax (+001-800-565-9774) and a confirmation copy by registered airmail for the attention of Ms. Susan Ball, General Counsel.
|
11.2
|
Any notice required to be served upon the Licensor shall be sufficiently served upon if posted by Registered A/D post or left at the address of the Licensor first given.
|
12.
|
STAMP DUTY & REGISTRATION
|
13.
|
NON-WAIVER
|
|
No failure on the part of the Licensor / Licensee to exercise, and no delay on the part of the Licensor / Licensee in exercising any right hereunder, shall operate as a waiver thereof, nor shall any single or partial exercise of any such right preclude any other or future exercise thereof or the exercise of any other right. The remedies herein are cumulative and not exclusive of any remedies provide by law.
|
14.
|
PARTIAL INVALIDITY
|
|
If at any time, any provision of this Agreement shall become or be held illegal, invalid or unenforceable in any respect under any law, then the legality, validity or enforceability of the remaining provisions shall not in any way be thereby effected or impaired. Any invalid or unenforceable provisions of this Agreement shall be replaced with a provision which is valid and enforceable and most nearly reflects the original intent of the invalid or enforceable provision.
|
16.
|
SUPERSESSION
|
|
This Agreement constitutes the entire agreement between the Licensor and Licensee and supersedes all prior understandings and writings between the parties.
|
17.
|
DISPUTE RESOLUTION MECHANISM
|
|
It is hereby agreed by and between the parties hereto that in case any disputes or difference arises between the parties with regards to the terms and conditions of this Agreements of relating to the Interpretation thereof, the same shall be referred to an arbitrator appointed on mutual consent of the Licensor and Licensee and such arbitration shall be in accordance with the provision of the Arbitration and Conciliation Act, 1996, or any statutory modification or re-enactment thereof for the time being in force. The arbitration shall be held in Pune and the proceedings shall be conducted in the English language. The parties agree that the arbitration awards shall be final and may be enforced as a degree. The parties further agree that only the competent courts of jurisdiction at Pune shall have exclusive jurisdiction in all matters arising thereunder. Notwithstanding the pending of settlement of any disputes or difference between the parties, the Licensee shall continue to pay
License Fee to the Licensor regularly and punctually, so long as the Licensee is in use and occupation of the Licensed Premises and the Licensor is not in violation of any of its obligations.
|
|
No alteration amendment or modification of any of the terms of this Agreement shall be valid and binding unless signed by or on behalf of both the parties hereto.
|
|
This Agreement shall be governed by Indian laws to the exclusive jurisdiction of the Courts in Pune only.
|
/s/ Subhash Gaikwad | |
Subhash Gaikwad | |
(Karta) |
1) | /s/ Ajit Gaikwad | |
Ajit Gaikwad |
survey no 126/2B Aundh, Pune-7 |
SIGNED AND DELIVERED | ||
for and on behalf of Licensee | ||
Crosscountry Infotech Pvt. Ltd | ||
/s/ Srinvas Ramulu Chidumalla | ||
Srinvas Ramulu Chidumalla (Vice President) |
In the presence of
|
|||
1) | /s/ Sudhir Gaikward | ||
Sudhir Gaikward | |||
WITNESSES: | WE SAY RECEIVED | |
/s/ Subhash Gaikwad | ||
Subhash Gaikwad (Karta) |
EXHIBIT 31.1
Certification
I, Joseph A. Boshart, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Cross Country Healthcare, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5.
The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
|
|
|
|
|
Date: | August 5, 2010 |
|
| /s/ JOSEPH A. BOSHART |
|
|
|
| Joseph A. Boshart President and Chief Executive Officer |
EXHIBIT 31.2
Certification
I, Emil Hensel, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Cross Country Healthcare, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5.
The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: | August 5, 2010 |
|
| /s/ EMIL HENSEL |
|
|
|
| Emil Hensel Chief Financial Officer |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the accompanying Quarterly Report on Form 10-Q of Cross Country Healthcare, Inc. (the Company) for the quarterly period ended June 30, 2010, (the Periodic Report), I, Joseph A. Boshart, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
|
Date: | August 5, 2010 |
|
| /s/ JOSEPH A. BOSHART |
|
|
|
| Joseph A. Boshart President and Chief Executive Officer |
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Cross Country Healthcare, Inc. and will be retained by Cross Country Healthcare, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is provided solely for purposes of complying with the provisions of Section 906 of the Sarbanes-Oxley Act of 2002.
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the accompanying Quarterly Report on Form 10-Q of Cross Country Healthcare, Inc. (the Company) for the quarterly period ended June 30, 2010, (the Periodic Report), I, Emil Hensel, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: | August 5, 2010 |
|
| /s/ EMIL HENSEL |
|
|
|
| Emil Hensel Chief Financial Officer |
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Cross Country Healthcare, Inc. and will be retained by Cross Country Healthcare, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is provided solely for purposes of complying with the provisions of Section 906 of the Sarbanes-Oxley Act of 2002.